resveratrol has been researched along with Neoplasms in 345 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (1.16) | 18.2507 |
| 2000's | 66 (19.13) | 29.6817 |
| 2010's | 196 (56.81) | 24.3611 |
| 2020's | 79 (22.90) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Anderson, FP; Butler, WE; Cloonan, S; Devery, A; Draper, SM; Kenny, PT; Moran, BW; Varughese, S | 1 |
| Abramson, HN | 1 |
| Cushman, M; Kondratyuk, TP; Marler, L; Mayhoub, AS; Park, EJ; Pezzuto, JM | 1 |
| Guo, Y; Huang, L; Li, X; Mao, F; Wang, Y; Yan, J | 1 |
| Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
| Altucci, L; Atlante, S; Budriesi, R; Carafa, V; Carnevale, I; Cencioni, C; Del Bufalo, D; Gabellini, C; Gaetano, C; Mai, A; Mellini, P; Moniot, S; Nebbioso, A; Polletta, L; Saladini, S; Spallotta, F; Steegborn, C; Tafani, M; Tardugno, M; Trisciuoglio, D; Valente, S; Zwergel, C | 1 |
| Benlloch, M; Castellano, G; Dellinger, RW; Estrela, JM; Mena, S; Obrador, E; Salvador, R | 1 |
| Ahn, MR; Maruta, H | 1 |
| Barbhuiya, TK; Jayaprakash, V; Mohd Siddique, MU; Sinha, BN | 1 |
| Kishore, N; Kumar, P; Shanker, K; Verma, AK | 1 |
| Kharkar, PS | 1 |
| Agboyibor, C; Bi, Y; Dong, J; Gong, H; Kang, L; Li, D; Li, J; Liu, H; Ma, X; Pervaiz, W; Tayyab, B; Zhang, H | 1 |
| Bhattacharya, S; Hoda, M; Jawed, JJ; Perris, A | 1 |
| Akter, R; Behl, T; Bungau, S; Bustea, C; Karthika, C; Kaushik, D; Mittal, V; Munteanu, MA; Nechifor, AC; Rahman, MH; Stoicescu, M; Uivarosan, D | 1 |
| Fu, X; Huang, Z; Li, M; Najafi, M; Tang, C | 1 |
| Akter, R; Bibi, P; Hassan, SSU; Mubin, S; Najda, A; Rahman, MH; Saeeda, S; Shah, M; Wesołowska, S | 1 |
| Asemi, Z; Maleki Dana, P; Sadoughi, F; Yousefi, B | 1 |
| Andersen, ML; Moreira, GA; Porcacchia, AS; Tufik, S | 1 |
| Dong, H; Jia, S; Yang, R; Yang, Z | 1 |
| Cheng, L; Huang, Y; Li, C; Li, T; Li, Y; Luo, Y; Wu, Z; Zhang, X; Zhao, Q; Zhou, K | 1 |
| Badgujar, V; Khan, A; Majeed, S; Murtuja, S; Robertson, I; Sajid Ali, M; Sami, F; Saquib Hasnain, M; Tahir Ansari, M; Wai Hau, T | 1 |
| Choi, CY; Han, SI; Lee, TB; Lim, SC | 1 |
| Hayakawa, S; Miyoshi, N; Ohishi, T | 1 |
| A Alsahli, M; Alhumaydhi, FA; Almatroodi, SA; Babiker, AY; Khan, AA; Rahmani, AH; S M Aljohani, A | 1 |
| Aschner, M; Bahabadi, ZR; Dashti, F; Davoodvandi, A; Gilasi, HR; Hamblin, MR; Kowsari, H; Mirazimi, SMA; Mirzaei, H; Sahebkar, A | 1 |
| Hamblin, MR; Homayounfal, M; Jafari, A; Loghman, A; Mirzaei, H; Roshani, M; Sheida, AH; Taghavi, T; Tamehri Zadeh, SS | 1 |
| Fukutomi, R; Miyoshi, N; Nakamura, Y; Ohishi, T; Yoshioka, Y | 1 |
| Chen, X; El-Kott, AF; Elsaid, FG; Ghanem, RA; Salem, ET; Xu, Z; Xue, J; Zhang, M | 1 |
| Ben-Zichri, S; Bhunia, SK; Jelinek, R; Rajendran, S | 1 |
| Chatterjee, S; Das, B; Das, C; Dash, SR; Kundu, CN; Paul, S; Sinha, S | 1 |
| Huang, P; Liu, F; Liu, J; Meng, C; Pan, X; Wang, J; Xia, C; Yuan, Z; Zhang, H; Zhao, H | 1 |
| Chen, J; Chen, JG; He, JH; He, SY; Huang, ST; Huang, ZH; Lin, WM; Ye, HY | 1 |
| Kalenik, S; Komorowska, D; Radzik, T; Rodacka, A | 1 |
| Abdelsalam, SA; Ahmed, EA; Ben Ammar, R; Rajendran, P; Renu, K; Veeraraghavan, V | 1 |
| Avula, B; Balachandran, P; Bennett, MM; Carr, MA; Kumarihamy, M; Lovell, KM; Marquart, ME; Muhammad, I; Nanayakkara, NPD; Tripathi, S; Wang, M; Wellington, OI; Zhang, J; Zhao, J | 1 |
| Amini, P; Dakkali, MS; Jafarzadeh, E; Johari, R; Khani, A; Khodamoradi, E; Moazamiyanfar, R; Mouludi, K; Najafi, M; Taeb, S | 1 |
| Bai, Z; Chen, L; Deng, L; Geng, H; Wang, G; Xia, C; Yao, J | 1 |
| Im, E; Jang, JY; Kim, ND | 1 |
| Huminiecki, L | 1 |
| Ballav, S; Basu, S; Ghosh, P; Lokhande, KB; Swamy, KV; Yadav, RS | 1 |
| Gadag, S; Garg, S; Narayan, R; Nayak, UY; Nayak, Y | 1 |
| Gao, J; Li, G; Li, S; Liu, K; Ma, F; Ma, Y; Sun, X | 1 |
| Fakhari, F; Khodamoradi, E; Lalani, AR; Moloudi, K; Najafi, M; Radgoudarzi, S; Rastegar-Pouyani, N; Taeb, S | 1 |
| Toca-Herrera, JL; Vivanco, MD; Weber, A | 1 |
| Asoodeh, A; Ghobadi, N | 1 |
| Celik, I; Gielecińska, A; Kałuzińska-Kołat, Ż; Kciuk, M; Kontek, R; Kołat, D; Mujwar, S | 1 |
| Chen, X; He, H; Jiang, W; Li, Y; Sun, M; Tian, W; Yu, J; Zhang, S | 1 |
| Asemi, R; Asemi, Z; Davoodvandi, A; Hajijafari, M; Hakamifard, A; Homayoonfal, M; Rajabpoor Nikoo, N; Shafabakhsh, R; Sharifi, M | 1 |
| Gulle, K; Ilhan, I; Sarman, E | 1 |
| Aghaz, F; Arkan, E; Asadi, Z; Kashfi, K; Rahimi, Z; Sajadimajd, S | 1 |
| Kesavan, Y; Pathak, S; Ramalingam, S; Srinivasan, SS | 1 |
| Al-Attar, T; Madihally, SV | 1 |
| Diederich, MF; Menezes, JCJMDS | 1 |
| Balan, P; Indrakumar, J; Korrapati, PS; Murali, P | 1 |
| Ahmed, MB; Lee, YS; Shehzad, A | 1 |
| Ahmadi, Z; Ashrafizadeh, M; Farkhondeh, T; Samarghandian, S | 1 |
| Ahmadi, A; Farhood, B; Mortezaee, K; Musa, AE; Najafi, M; Shabeeb, D | 1 |
| Hsieh, TC; Wu, JM | 1 |
| Amiri, A; Asemi, Z; Hajighadimi, S; Mahjoubin-Tehran, M; Mirzaei, H; Mirzaei, HR; Moradizarmehri, S; Shafiee, A | 1 |
| Latruffe, N; Vervandier-Fasseur, D | 1 |
| Bosch-Barrera, J; Brunet, J; Cortada, E; Cuyàs, E; Encinar, JA; Lopez-Bonet, E; Martin-Castillo, B; Menendez, JA; Verdura, S | 1 |
| Bishayee, A; Daglia, M; Diniz, M; Lagoa, R; Marques-da-Silva, D | 1 |
| Ferraz da Costa, DC; Ferreira, VF; Ferretti, GDDS; Martins-Dinis, MMDDC; Pereira Rangel, L; Silva, JL | 1 |
| Ashrafizadeh, M; Farkhondeh, T; Garg, M; Javanmardi, S; Mohammadinejad, R; Moradi-Ozarlou, M; Samarghandian, S | 1 |
| Gan, YH; Ge, LP; Kang, YF; Li, YP; Liu, LN; Meng, YL; Xin, ZH; Yang, HH; Zhang, CH | 1 |
| Adhami, VM; Jabir, NR; Kamal, MA; Khan, MI; Moulay, M; Mukhtar, H; Tabrez, S | 1 |
| Aasbrenn, M; Abd El-Aty, AM; Abdu, A; Abraha, HB; Achour, A; Acquaroni, M; Addeo, P; Agback, P; Agback, T; Al-Alwan, M; Al-Mazrou, A; Al-Mohanna, F; Aliste, M; Almquist, J; Andel, J; Ando, M; Angelov, A; Annuar, MSM; Antwi, K; Arroliga, AC; Arruda, SLM; Asch, SM; Averous, G; Ayaz, S; Ayer, GB; Bachellier, P; Ball, S; Banijamali, AR; Barden, TC; Bartoncini, S; Bedanie, G; Bellò, M; Benić, F; Berhe, GG; Bertiger, G; Beumer, JH; Bhandari, B; Bond, DS; Boules, M; Braüner Christensen, J; Brown-Johnson, C; Burgstaller, S; Cao, L; Capasso, C; Carlevato, R; Carvalho, AE; Ceci, F; Chagas, ATA; Chavan, SG; Chen, AP; Chen, HC; Chen, J; Chen, Q; Chen, Y; Chen, YF; Christ, ER; Chu, CW; Covey, JM; Coyne, GO'; Cristea, MC; Currie, MG; Dahdal, DN; Dai, L; Dang, Z; de Abreu, NL; de Carvalho, KMB; de la Plaza Llamas, R; Deandreis, D; Del Prete, S; Dennis, JA; Deur, J; Díaz Candelas, DA; Divyapriya, G; Djanani, A; Dodig, D; Doki, Y; Doroshow, JH; Dos Santos, RC; Durairaj, N; Dutra, ES; Eguchi, H; Eisterer, W; Ekmann, A; Elakkad, A; Evans, WE; Fan, W; Fang, Z; Faria, HP; Farris, SG; Fenoll, J; Fernandez-Botran, R; Flores, P; Fujita, J; Gan, L; Gandara, DR; Gao, X; Garcia, AA; Garrido, I; Gebru, HA; Gerger, A; Germano, P; Ghamande, S; Ghebeh, H; Giver Jensen, T; Go, A; Goichot, B; Goldwater, M; Gontero, P; Greil, R; Gruenberger, B; Guarneri, A; Guo, Y; Gupta, S; Haxholdt Lunn, T; Hayek, AJ; He, ML; Hellín, P; Hepprich, M; Hernández de Rodas, E; Hill, A; Hndeya, AG; Holdsworth, LM; Hookey, L; Howie, W; Hu, G; Huang, JD; Huang, SY; Hubmann, E; Hwang, SY; Imamura, H; Imperiale, A; Jiang, JQ; Jimenez, JL; Jin, F; Jin, H; Johnson, KL; Joseph, A; Juwara, L; Kalapothakis, E; Karami, H; Karayağiz Muslu, G; Kawabata, R; Kerwin, J; Khan, I; Khin, S; Kidanemariam, HG; Kinders, RJ; Klepov, VV; Koehler, S; Korger, M; Kovačić, S; Koyappayil, A; Kroll, MH; Kuban, J; Kummar, S; Kung, HF; Kurokawa, Y; Laengle, F; Lan, J; Leal, HG; Lee, MH; Lemos, KGE; Li, B; Li, G; Li, H; Li, X; Li, Y; Li, Z; Liebl, W; Lillaz, B; Lin, F; Lin, L; Lin, MCM; Lin, Y; Lin, YP; Lipton, RB; Liu, J; Liu, W; Liu, Z; Lu, J; Lu, LY; Lu, YJ; Ludwig, S; Luo, Y; Ma, L; Ma, W; Machado-Coelho, GLL; Mahmoodi, B; Mahoney, M; Mahvash, A; Mansour, FA; Mao, X; Marinho, CC; Masferrer, JL; Matana Kaštelan, Z; Melendez-Araújo, MS; Méndez-Chacón, E; Miletić, D; Miller, B; Miller, E; Miller, SB; Mo, L; Moazzen, M; Mohammadniaei, M; Montaz-Rosset, MS; Mousavi Khaneghah, A; Mühlethaler, K; Mukhopadhyay, S; Mulugeta, A; Nambi, IM; Navarro, S; Nazmara, S; Neumann, HJ; Newman, EM; Nguyen, HTT; Nicolato, AJPG; Nicolotti, DG; Nieva, JJ; Nilvebrant, J; Nocentini, A; Nugent, K; Nunez-Rodriguez, DL; Nygren, PÅ; Oberli, A; Oderda, M; Odisio, B; Oehler, L; Otludil, B; Overman, M; Özdemir, M; Pace, KA; Palm, H; Parchment, RE; Parise, R; Passera, R; Pavlovic, J; Pecherstorfer, M; Peng, Z; Pérez Coll, C; Petzer, A; Philipp-Abbrederis, K; Pichler, P; Piekarz, RL; Pilati, E; Pimentel, JDSM; Posch, F; Prager, G; Pressel, E; Profy, AT; Qi, P; Qi, Y; Qiu, C; Rajasekhar, B; Ramia, JM; Raynor, HA; Reis, VW; Reubi, JC; Ricardi, U; Riedl, JM; Romano, F; Rong, X; Rubinstein, L; Rumboldt, Z; Sabir, S; Safaeinili, N; Sala, BM; Sandoval Castillo, L; Sau, M; Sbhatu, DB; Schulte, T; Scott, V; Shan, H; Shao, Y; Shariatifar, N; Shaw, JG; She, Y; Shen, B; Shernyukov, A; Sheth, RA; Shi, B; Shi, R; Shum, KT; Silva, JC; Singh, A; Sinha, N; Sirajudeen, AAO; Slaven, J; Sliwa, T; Somme, F; Song, S; Steinberg, SM; Subramaniam, R; Suetta, C; Sui, Y; Sun, B; Sun, C; Sun, H; Sun, Y; Supuran, CT; Surger, M; Svartz, G; Takahashi, T; Takeno, A; Tam, AL; Tang, Z; Tanner, JA; Tannich, E; Taye, MG; Tekle, HT; Thomas, GJ; Tian, Y; Tobin, JV; Todd Milne, G; Tong, X; Une, C; Vela, N; Venkateshwaran, U; Villagrán de Tercero, CI; Wakefield, JD; Wampfler, R; Wan, M; Wang, C; Wang, J; Wang, L; Wang, S; Waser, B; Watt, RM; Wei, B; Wei, L; Weldemichael, MY; Wellmann, IA; Wen, A; Wild, D; Wilthoner, K; Winder, T; Wing, RR; Winget, M; Wöll, E; Wong, KL; Wong, KT; Wu, D; Wu, Q; Wu, Y; Xiang, T; Xiang, Z; Xu, F; Xu, L; Yamasaki, M; Yamashita, K; Yan, H; Yan, Y; Yang, C; Yang, H; Yang, J; Yang, N; Yang, Y; Yau, P; Yu, M; Yuan, Q; Zhan, S; Zhang, B; Zhang, H; Zhang, J; Zhang, N; Zhang, Y; Zhao, X; Zheng, BJ; Zheng, H; Zheng, W; Zhou, H; Zhou, X; Zhu, S; Zimmer, DP; Zionts, D; Zitella, A; Zlott, J; Zolfaghari, K; Zuo, D; Zur Loye, HC; Žuža, I | 1 |
| Berretta, M; Bignucolo, A; Ceccarelli, M; Comello, F; Di Francia, R; Facchini, G; Iaffaioli, RV; Maurea, N; Quagliariello, V | 1 |
| Gulyayev, A; Krivykh, E; Masoud, AR; Nurgozhin, T; Saliev, T; Sergazy, S; Umbayev, B; Yessenkyzy, A; Zhanaliyeva, M | 1 |
| Abrego, J; Attri, KS; Buettner, K; Chaika, NV; Dasgupta, A; Engle, DD; Grandgenett, PM; Graves, G; Hollingsworth, MA; King, RJ; Klute, KA; Mehla, K; Mulder, SE; Mullen, NJ; Murthy, D; Oberley-Deegan, R; Pacheco, CG; Punsoni, M; Rai, I; Reames, BN; Sadoshima, J; Shukla, SK; Singh, PK; Teoh-Fitzgerald, M; Thakur, R; Tuveson, DA; Vernucci, E; Wang, D; Yu, F; Zimmerman, MC | 1 |
| D'Arcy, MS | 1 |
| Basili, S; Cangemi, R; Corica, B; Raparelli, V; Romiti, GF | 1 |
| Cao, W; Liu, R; Liu, Z; Qian, W; Sun, H; Wang, D; Yu, D; Zhang, T; Zhang, Z; Zhong, C | 1 |
| Giovinazzo, G; Poltronieri, P; Xu, B | 1 |
| Borriello, A; Cervellera, C; Russo, GL; Stampone, E | 1 |
| Ballav, S; Basu, S; Lokhande, KB; Swamy, KV; Yadav, RS | 1 |
| Al Kury, LT; Alsayed, AR; Farhan, F; Talib, WH | 1 |
| Li, SS; Liu, RR; Meng, YJ; Muhire, J; Yin, B; Zhai, HL | 1 |
| Malik, S; Manne, U; Mishra, MK; Owonikoko, TK; Singh, R; Stokes Iii, J; Vinayak, S; Williams, J | 1 |
| Afrashi, S; Ashrafizadeh, M; Farhood, B; Haghi-Aminjan, H; Moloudi, K; Musa, AE; Najafi, M; Taeb, S | 1 |
| Gao, J; Li, G; Ma, F; Wang, X | 1 |
| Behera, C; Bhutia, SK; Efferth, T; Jena, M; Nayak, R; Patra, S; Pradhan, B; Rout, L | 1 |
| Chen, DW; Gao, Y; Hu, HY; Jia, L; Qiao, MX; Zhao, XL; Zhou, T | 1 |
| Annaji, M; Arnold, RD; Babu, RJ; Boddu, SHS; Poudel, I; Tiwari, AK | 1 |
| Berretta, M; Cocetta, V; Fiorica, F; Montopoli, M; Quagliariello, V | 1 |
| Ahmad, N; Akula, N; Amiri, D; Chhabra, G; Singh, CK | 1 |
| Ding, L; Goh, BC; Ho, PC; Kwah, MX; Liu, C; Ma, Z; Ong, PS; Ren, B; Shanmugam, MK; Wang, L; Xiang, X | 1 |
| Gąsiorowski, K; Szafran, RG; Wiatrak, B | 1 |
| Chen, L; Musa, AE | 1 |
| Mu, Q; Najafi, M | 1 |
| Catalina Ardila, D; Gadag, S; Garg, S; Narayan, R; Nayak, AS; Nayak, UY; Nayak, Y; Sant, S | 1 |
| Cimino, F; Citarella, A; Cristani, M; Micale, N; Molonia, MS; Saija, A; Speciale, A | 1 |
| Kaur, A; Ramachandran, V; Tiwari, G; Tiwari, R | 1 |
| Barreiro, E; Duran, X; López-Postigo, A; Mateu, J; Penedo-Vázquez, A | 1 |
| Bergmayr, C; Buchleitner, S; Dvorak, Z; Fazekas, J; Jensen-Jarolim, E; Manzano-Szalai, K; Meitz, S; Moskovskich, A; Müller, MA; Neunkirchner, A; Roth, GA; Roth-Walter, F; Stremnitzer, C | 1 |
| Abdollahi, M; Bahramsoltani, R; Davatgaran-Taghipour, Y; Farzaei, MH; Karimi-Soureh, Z; Masoomzadeh, S; Rahimi, R | 1 |
| Abrams, SL; Candido, S; Cervello, M; Cocco, L; Gizak, A; Lertpiriyapong, K; Libra, M; Martelli, AM; McCubrey, JA; Montalto, G; Rakus, D; Ratti, S; Steelman, LS | 1 |
| Ferraz da Costa, DC; Fialho, E; Silva, JL | 1 |
| Andrade Volkart, P; Arigony Souto, A; Benedetti Gassen, R; Eduardo Vargas, J; Mühlen Nogueira, B; Nery Porto, B | 1 |
| Chen, KM; Hassanshahi, M; Howe, PR; Su, YW; Tang, Q; Xian, CJ | 1 |
| Bonferoni, MC; Ferrari, F; Rossi, S; Sandri, G | 1 |
| Freiesleben, S; Gupta, SK; Shukla, Y; Singh, N; Wolkenhauer, O | 1 |
| Arany, I; Dixit, M; Faisal, A; Hall, S | 1 |
| Chen, J; Gao, K; Jia, C; Murtaza, G; Tian, G; Wahab, A; Zhang, F | 1 |
| Byun, S; Lee, E; Lee, KW | 1 |
| Chen, YR; Chin, YT; Davis, PJ; Ho, Y; Lin, HY; Lin, SY; Lin, YS; Liu, HL; Shih, A; Shih, YJ | 1 |
| Cao, J; Chen, K; Cheng, L; Jiang, Z; Li, J; Ma, Q; Qian, W; Wu, E; Yan, B; Yang, W | 1 |
| Abrams, SL; Candido, S; Cervello, M; Cocco, L; Gizak, A; Lertpiriyapong, K; Libra, M; Lombardi, P; Martelli, AM; McCubrey, JA; Montalto, G; Murata, RM; Rakus, D; Ratti, S; Rosalen, PL; Steelman, LS | 1 |
| Katnoria, JK; Kaur, M; Nagpal, AK; Sharma, A | 1 |
| Ahmad, B; Imran, M; Mubarak, MS; Peters, DG; Rauf, A; Suleria, HAR | 1 |
| Dutra, LA; Heidenreich, D; Knapp, S; Man Chin, C; Santos, JLD; Silva, GDBD | 1 |
| Chang, WW; Kuan, YD; Lee, CH; Lin, HC; Wang, WK; Yang, CJ | 1 |
| Ahn, KS; Arfuso, F; Bishayee, A; Ko, JH; Kumar, AP; Sethi, G; Shanmugam, MK; Um, JY | 1 |
| Li, S; Li, YR; Lin, CC | 1 |
| Chiou, YS; Ho, CT; Lee, PS; Pan, MH | 1 |
| Valentovic, MA | 1 |
| Ahmad, A; Farooqi, AA; Khalid, S | 1 |
| Chiu, JF; Deng, Y; Fan, Y; Li, G; Liu, J; Xu, C; Zhang, J | 1 |
| Bernardi, A; de Sá Coutinho, D; Frozza, RL; Pacheco, MT | 1 |
| Gao, H; Liu, B; Ma, Y; Mao, Z; Wan, C; Zhang, L; Zheng, X; Zhu, P | 1 |
| Chen, L; Chen, X; Dong, X; Hu, X; Huang, S; Li, Y; Ma, J; Zhang, R; Zhu, C | 1 |
| Efferth, T; Fischer, N; Seo, EJ | 1 |
| Carbone, ML; Lulli, D; Passarelli, F; Pastore, S | 1 |
| Ajaiyeoba, EO; Evans, AR; Ismail, FMD; Nahar, L; Ogbole, OO; Sarker, SD; Segun, PA | 1 |
| Batinić, J; Bjeliš, N; Jakas, A; Mrkus, L | 1 |
| Cheng, L; Duan, W; Ma, J; Qian, W; Shen, X; Xue, M; Zhang, S | 1 |
| Bhatia, D; Shi, Q | 1 |
| Bhatnagar, A; Pannu, N | 1 |
| de Medina, P | 1 |
| Deora, GS; Li, QS; Li, Y; Ruan, BF | 1 |
| El-Kholy, AI; Fadel, M; Kassab, K; Youssef, T | 1 |
| Gupta, SC; Kaschula, CH; Maiti, P; Rai, V; Singh, AP; Singh, R; Verma, SS | 1 |
| Cho, JH; Dhanasekaran, DN; Han, Y; Jo, H; Song, YS | 1 |
| Arnold, M; Huang, YW; Oshima, K; Pan, P; Wang, LS; Yearsley, M; Yu, J; Zhang, J | 1 |
| Aebisher, D; Bartusik-Aebisher, D; Galiniak, S | 1 |
| Abdelgawad, IY; Grant, MKO; Zordoky, BN | 1 |
| Belmont-Díaz, J; Gallardo-Pérez, JC; García-García, JD; Hernández-Esquivel, L; Hernández-Reséndiz, I; López-Marure, R; Marín-Hernández, Á; Moreno-Sánchez, R; Pacheco-Velázquez, SC; Robledo-Cadena, DX; Rodríguez-Enríquez, S; Sánchez-Thomas, R | 1 |
| Awasthee, N; Challagundla, KB; Chava, S; Gupta, SC; Hui, KM; Kumar, AP; Mishra, S; Rai, V; Sethi, G; Verma, SS | 1 |
| Cao, Y; Kong, L; Smith, W; Yan, L | 1 |
| Emamat, H; Farhadnejad, H; Zand, H | 1 |
| Jiang, S; Wang, K; Wang, M; Yu, F; Zhou, L | 1 |
| Caldas, M; Ferreira, L; Figueiras, A; Magalhães, M; Pereira, I; Pereira-Silva, M; Ribeiro, AJ; Santos, AC; Veiga, F | 1 |
| Andreoletti, P; Cherkaoui-Malki, M; Latruffe, N; Silva, P; Sureda, A; Tur, JA | 1 |
| Kassayová, M; Kisková, T | 1 |
| Chen, RJ; Chen, YY; Lee, YH; Wang, YJ; Yeh, YL | 1 |
| Dántola, ML; Gaspar Tosato, M; Lorente, C; Neyra Recky, JR; Serrano, MP; Thomas, AH | 1 |
| Molt, M; Salas, M; Uribe, E; Zambrano, A | 1 |
| Lançon, A; Latruffe, N; Michaille, JJ | 1 |
| Beaudeux, JL; Cottart, CH; Nivet-Antoine, V | 1 |
| Godelmann, R; Lachenmeier, DW; Rehm, J; Riedel, K; Witt, B | 1 |
| Li, Y; Sarkar, FH; Sethi, S | 1 |
| Vang, O | 1 |
| Brown, K; Gescher, A; Steward, WP | 1 |
| Kondratyuk, TP; Ogas, T; Pezzuto, JM | 1 |
| Aires, V; Colin, DJ; Cotte, AK; Delmas, D; Ghiringhelli, F; Limagne, E; Scagliarini, A | 1 |
| Ahmad, N; George, J; Singh, CK | 1 |
| Chen, X; Ge, HM; Hou, Y; Li, E; Qiao, H; Tan, RX; Wang, J; Xu, L; Zhao, G | 1 |
| Anuradha, CM; Banaganapalli, B; Gudla, D; Mulakayala, C; Mulakayala, N; Pulaganti, M; Shaik, NA; Suresh Kumar, C; Yousuf Al-Aama, J | 1 |
| Bencivenga, D; Borgia, A; Borriello, A; Caldarelli, I; Della Ragione, F; Tramontano, A; Zappia, V | 1 |
| Abdollahi, M; Saeidnia, S | 1 |
| Resurreccion, AV; Sales, JM | 1 |
| Kma, L | 1 |
| Carter, LG; D'Orazio, JA; Pearson, KJ | 1 |
| Cerella, C; Dicato, M; Diederich, M; Gaigneaux, A | 1 |
| Mihăilă, RG | 1 |
| Burkewitz, K; Mair, WB; Zhang, Y | 1 |
| Cheng, KJ; Di, JM; Luo, Y; Shi, Z; Wei, X; Xue, YQ | 1 |
| Andres-Lacueva, C; Bandinelli, S; Bartali, B; Cherubini, A; Ferrucci, L; Semba, RD; Sun, K; Urpí-Sarda, M; Zamora-Ros, R | 1 |
| Li, X; Ren, J; Yang, X | 1 |
| Aras, A; Farooqi, AA; Hechenleitner, AA; Khokhar, AR; Pineda, EA; Qureshi, MZ; Silva, MF; Sobczak-Kupiec, A | 1 |
| Choi, YJ; Jeong, MH; Jeong, SK; Jo, WS; Lee, CW; Lee, KY; Oh, SJ; Park, YS; Yang, K | 1 |
| Chun, M; Kim, HS; Kim, KO; Park, H | 1 |
| Barale, R; Bavaresco, L; Faliva, MA; Gerbi, V; Giacosa, A; La Vecchia, C; Negri, E; Opizzi, A; Perna, S; Pezzotti, M; Rondanelli, M | 1 |
| Howes, MJ; Simmonds, MS | 1 |
| Nagoor, NH; Phuah, NH | 1 |
| Hu, Y; Li, C; Li, H; Li, M; Shu, X | 1 |
| Kang, C; Roh, C | 1 |
| Anthony, NG; Gray, AI; Lim, KG; Mackay, SP; Pyne, NJ; Pyne, S | 1 |
| Hasima, N; Ozpolat, B | 1 |
| Arola, L; Garcia-Vallve, S; Mulero, M; Pan-Castillo, B; Pujadas, G; Rojas, C; Valls, C | 1 |
| Cho, YS; Jung, KH; Lee, JH; Lee, KH; Moon, SH; Park, JW; Quach, CHT | 1 |
| Ahmad, N; Ndiaye, MA; Singh, CK | 1 |
| Aires, V; Delmas, D | 1 |
| Aldawsari, FS; Velázquez-Martínez, CA | 1 |
| Arumuggam, N; Bhowmick, NA; Rupasinghe, HP | 1 |
| Iqbal, Z; Khuroo, T; Talegaonkar, S; Verma, D | 1 |
| Brasili, E; Filho, VC | 1 |
| Ahmad, N; Mukhtar, H; Sanna, V; Sechi, M; Siddiqui, IA | 1 |
| Alayev, A; Berger, SM; Holz, MK | 1 |
| Chi, TF; Dimova, EY; Ganjam, GK; Kietzmann, T | 1 |
| Fang, JY; Han, B; Hoang, BX; Nimni, M; Shaw, DG | 1 |
| Nelson, B | 1 |
| Khan, M; Ma, T; Maryam, A; Mehmood, T; Zhang, Y | 1 |
| Agrawal, M | 1 |
| Cragg, GM; Pezzuto, JM | 1 |
| Bukhari, SN; Jantan, I; Seyed, MA; Vijayaraghavan, K | 1 |
| Asensi, MA; Estrela, JM; Mena, S; Ortega, AL; Rodríguez, ML; Sirerol, JA | 1 |
| Daglia, M; de Oliveira, MR; Hajheydari, Z; Manayi, A; Nabavi, SF; Nabavi, SM | 1 |
| Ahmad, N; El-Abd, S; Mukhtar, H; Siddiqui, IA; Singh, CK | 1 |
| Sanna, V; Siddiqui, IA | 1 |
| Bayliss, R; Brown, K; Gescher, A; Howells, L; Karmokar, A; Khan, S; Thomas, AL | 1 |
| Burkard, M; Busch, C; Lauer, UM; Leischner, C; Pfeiffer, MM; Venturelli, S | 1 |
| Giacomini, E; Guidotti, L; Recanatini, M; Roberti, M; Rupiani, S | 1 |
| Adrian, JA; Kondratyuk, TP; Morris, KR; Park, EJ; Pezzuto, JM; van Breemen, RB; Wright, B | 1 |
| Choi, KC; Hwang, KA; Lee, GA | 1 |
| Erdogan, CS; Vang, O | 1 |
| Bai, X; Ma, X; Xu, X; Yao, L | 1 |
| Das, J; Ramani, R; Suraju, MO | 1 |
| Bai, Y; Hao, L; Hu, W; Lv, Y; Ran, Y; Zhang, L | 1 |
| Dhatwalia, SK; Dhawan, DK; Kumar, M | 1 |
| Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW | 1 |
| Eitsuka, T; Miyazawa, T; Nakagawa, K; Nishida, H; Tatewaki, N | 1 |
| Cozzi, R; Degrassi, F; Fiore, M; Percario, Z; Traversi, G | 1 |
| Choudhary, B; Gopalakrishnan, V; Hegde, M; Karki, SS; Kumar, S; Raghavan, SC; Thomas, E | 1 |
| Chiba, DE; Dos Santos, JL; Fernandes, GF; Jornada, DH; Man Chin, C; Pavan, AR; Silva, GD | 1 |
| Kamaleddin, MA | 1 |
| Choi, KC; Hwang, KA; Kim, CW | 1 |
| Li, H; Li, Z; Wang, Y; Wu, C; Wu, H; Yang, P | 1 |
| Butt, MS; Imran, M; Mubarak, MS; Nadeem, M; Peters, DG; Rauf, A | 1 |
| Nandagopal, K; Routh, S | 1 |
| Bishayee, A; Daglia, M; Nabavi, SF; Nabavi, SM; Pandima Devi, K; Rajavel, T | 1 |
| Hattori, K; Hattori, Y; Inoue, S; Noguchi, M; Ohashi, W; Suzuki, T; Takashina, M; Tomihara, K; Tomita, K; Zhao, QL | 1 |
| Marciniak, S; Rajtar, G; Walczak, K | 1 |
| León, D; Salas, M; Uribe, E; Zambrano, A | 1 |
| Borges, PA; da Silva Barros, RG; de Oliveira, MR; de Rossi, FT; Jardim, FR; Nascimento, MX; Prescilio, IC | 1 |
| Gong, Y; Guo, H; Hou, D; Li, B; Liu, Q; Shao, C; Xu, X; Zhang, S; Zhang, X; Zhou, H; Zou, Y | 1 |
| Bai, Y; Fan, E; Jiang, S; Zhang, L | 1 |
| Appella, E; Cao, L; Chilton, B; Deng, CX; Jia, R; Kim, HS; Kim, S; Li, C; Ried, T; Sengupta, K; Wang, RH; Wang, XW; Xiao, C; Xu, X; Zheng, Y; Zheng, ZM | 1 |
| Beau, I; Codogno, P; Ghidoni, R; Maffei, R; Scarlatti, F | 1 |
| Hail, N; Lotan, R | 1 |
| Das, DK; Goswami, SK | 1 |
| Kong, D; Li, Y; Sarkar, FH; Wang, Z | 1 |
| Bishayee, A | 1 |
| Cheson, BD | 1 |
| Davis, FB; Davis, PJ; Hercbergs, AH; Lin, HY; Luidens, MK; Mousa, SA; Tang, HY | 1 |
| Cantos-Villar, E; García-Parrilla, MC; Guerrero, RF; Puertas, B | 1 |
| Athar, M; Back, JH; Bickers, DR; Kim, AL; Kopelovich, L | 1 |
| Chen, Y; Li, B; Liu, CG; Liu, X; Ren, X; Wu, H; Yang, JM; Zhu, H | 1 |
| Henry, GE; Li, L; Seeram, NP | 1 |
| Jung, M; Schemies, J; Sippl, W; Uciechowska, U | 1 |
| Baur, JA | 1 |
| Chen, WJ; Kuo, DH; Lin, JN; Lin, VC; Rau, KM; Shieh, JC; Shieh, PC; Tsai, SC; Way, TD | 1 |
| Cavalieri, EL; Rogan, EG | 1 |
| Czerwiecki, L | 1 |
| Ahmad, A; Azmi, AS; Hadi, SM; Khan, HY; Shamim, U; Ullah, MF; Zubair, H | 1 |
| Fritzer-Szekeres, M; Jäger, W; Saiko, P; Szekeres, T | 1 |
| Chen, ZX; Low, IC; Pervaiz, S | 1 |
| Efferth, T; Kraft, TE; Parisotto, D; Schempp, C | 1 |
| Fulda, S | 3 |
| Cushman, M; Hoshino, J; Jermihov, K; Marler, L; Mesecar, AD; Pezzuto, JM; Sun, B | 1 |
| Fukui, M; Kang, KS; Yamabe, N; Zhu, BT | 1 |
| Ignatowicz, E; Mikstacka, R | 1 |
| Argilés, JM; Barberis, P; Busquets, S; Figueras, M; Fontes de Oliveira, C; López-Soriano, FJ; Olivan, M; Sette, A; Toledo, M; Ventura da Silva, P | 1 |
| Dicato, M; Diederich, M; Jacob, C; Kelkel, M | 1 |
| Nau, JY | 1 |
| Kelly, G | 1 |
| Kelly, GS | 1 |
| Robb, EL; Stuart, JA | 1 |
| Shukla, Y; Singh, R | 1 |
| Namasivayam, N | 1 |
| Djavan, B; Fritzer-Szekeres, M; Jäger, W; Saiko, P; Szekeres, T | 1 |
| Pezzuto, JM | 2 |
| Ahmad, N; Kumar, R; Ndiaye, M | 1 |
| Aggarwal, BB; Gupta, SC; Kannappan, R; Kim, JH; Reuter, S | 1 |
| Kannaiyan, R; Sethi, G; Shanmugam, MK | 1 |
| Li, Y; Schwartz, SJ; Sun, D; Wicha, MS | 1 |
| Mikulski, D; Molski, M; Szeląg, M | 1 |
| DeWeerdt, S | 1 |
| Kaminski, BM; Stein, JM; Steinhilber, D; Ulrich, S | 1 |
| Darjatmoko, SR; Gillies, SD; Hank, JA; Kim, K; Polans, AS; Rakhmilevich, AL; Reisfeld, RA; Seo, S; Sondel, PM; Soto, BL; Yanke, EM | 1 |
| Hardy, TM; Tollefsbol, TO | 1 |
| Russo, GL; Russo, M; Spagnuolo, C; Tedesco, I | 1 |
| Brown, K; Gescher, AJ; Scott, E; Steward, WP | 1 |
| Gray, AI; Lim, KG; Pyne, NJ; Pyne, S | 1 |
| Azmi, AS; Bao, B; Beck, FW; Hadi, SM; Mohammad, RM; Muqbil, I; Sarkar, FH | 1 |
| Cruz-Calvo, SS; Lopez-Lluch, G; Navas, P | 1 |
| Aluyen, JK; Bellanger, RA; Gottlieb, HB; Ton, QN; Tran, T; Yang, AE | 1 |
| Solari, F; Terret, C | 1 |
| Baek, SJ; Whitlock, NC | 1 |
| Kaminski, J; Lançon, A; Latruffe, N; Michaille, JJ; Tili, E | 1 |
| Bot, A | 1 |
| Burdan, F; Fraczek, M; Podlodowska, J; Szumiło, J | 1 |
| Estrela, JM; Jäättela, M; Mena, S; Ortega, AL; Ponsoda, X; Rodríguez, ML | 1 |
| Vetvicka, V; Vetvickova, J | 1 |
| Bourzac, K | 1 |
| Berman-Booty, L; Omar, HA; Weng, JR | 1 |
| Liu, F; Wu, Y | 1 |
| Chae, SH; Chun, SH; Jung, ID; Kang, HK; Noh, KT; Park, YM | 1 |
| Bencivenga, D; Borgia, A; Borriello, A; Caldarelli, I; Della Ragione, F; Oliva, A; Pirozzi, AV; Tramontano, A | 1 |
| Berlot, JP; Cherkaoui Malki, M; Delmas, D; Jannin, B; Latruffe, N; Passilly-Degrace, P | 1 |
| Binkoski, AE; Bonanome, A; Coval, SM; Etherton, TD; Griel, AE; Hecker, KD; Hilpert, KF; Kris-Etherton, PM | 1 |
| Rosenkranz, HS; Thampatty, BP | 1 |
| Mahyar-Roemer, M; Roemer, K | 1 |
| Bonavida, B; Cal, C; Garban, H; Jazirehi, A; Mizutani, Y; Yeh, C | 1 |
| Ahmad, N; Aziz, MH; Kumar, R | 1 |
| Frank, GC | 1 |
| Granados-Soto, V | 1 |
| Bianchini, F; Vainio, H | 1 |
| Gescher, AJ; Steward, WP | 1 |
| Seaver, B; Smith, JR | 1 |
| Kundu, JK; Surh, YJ | 1 |
| Schultz, J | 1 |
| Castello, L; Tessitore, L | 1 |
| Bracke, M; Bruyneel, E; Garel, MC; Gespach, C; Navarro, N; Porteu, F; Rodrigue, CM; Romeo, PH | 1 |
| Pervaiz, S | 2 |
| Dulak, J | 1 |
| Carter, B; Cilenti, L; Jove, R; Khaled, A; Kotha, A; Sekharam, M; Siddiquee, K; Turkson, J; Zervos, AS | 1 |
| Colin, D; Delmas, D; Jannin, B; Lançon, A; Latruffe, N | 1 |
| Baur, JA; Sinclair, DA | 1 |
| Szumiło, J | 1 |
| Lee, HJ; Lee, KW | 1 |
| Debatin, KM; Fulda, S | 1 |
| Chan, TH; Chen, D; Dou, QP; Landis-Piwowar, KR; Milacic, V; Yan, B; Yang, H; Zhao, Y | 1 |
| Athar, M; Back, JH; Bickers, DR; Kim, AL; Kim, KH; Kopelovich, L; Tang, X | 1 |
| Boocock, DJ; Booth, TD; Brenner, DE; Brown, VA; Crowell, JA; Ducharme, MP; Faust, GE; Gescher, AJ; Patel, KR; Perloff, M; Schinas, AM; Steward, WP | 1 |
| Shankar, S; Singh, G; Srivastava, RK | 1 |
| Dirsch, VM; Heiss, EH; Schilder, YDC | 1 |
| Andreadi, CK; Foreman, BE; Howells, LM; Hudson, EA; Manson, MM; Moiseeva, EP; Neal, CP; Sun, YY | 1 |
| Katiyar, SK; Meeran, SM | 1 |
| Liu, BL; Zhang, W; Zhang, X; Zhen, HN | 1 |
| Afaq, F; Khan, N; Mukhtar, H | 1 |
| Gatz, SA; Wiesmüller, L | 1 |
| Aggarwal, BB; Harikumar, KB | 1 |
| Lin, JK; Tsai, SH | 1 |
| Gottlieb, N | 1 |
| Surh, Y | 1 |
| Ahmad, A; Farhan Asad, S; Hadi, SM; Singh, S | 1 |
| Olas, B; Wachowicz, B | 1 |
| Atassi, G; Gusman, J; Malonne, H | 1 |
| Diamandis, EP; Goldberg, DM; Soleas, GJ | 1 |
| Ciolino, HP; Yeh, GC | 1 |
| Bråkenhielm, E; Cao, R; Cao, Y | 1 |
| Burke, MD; Butler, PC; Farmer, PB; Ijaz, T; Lamb, JH; Patterson, LH; Perry, PJ; Potter, GA; Ruparelia, KC; Stanley, LA; Wanogho, E | 1 |
| Quesne, M; Savouret, JF | 1 |
| Bhat, KP; Pezzuto, JM | 1 |
| Anderson, DE; Greenwald, P; McDonald, SS; Milner, JA | 1 |
227 review(s) available for resveratrol and Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
From bench (laboratory) to bed (hospital/home): How to explore effective natural and synthetic PAK1-blockers/longevity-promoters for cancer therapy.
Topics: Animals; Antineoplastic Agents; Click Chemistry; Drug Discovery; Humans; Longevity; Neoplasms; p21-Activated Kinases; Protein Kinase Inhibitors | 2017 |
Phytoestrogens and their synthetic analogues as substrate mimic inhibitors of CYP1B1.
Topics: Animals; Antineoplastic Agents, Phytogenic; Classification; Cluster Analysis; Cytochrome P-450 CYP1B1; Enzyme Inhibitors; Humans; Molecular Mimicry; Neoplasms; Phytoestrogens | 2019 |
Human disorders associated with inflammation and the evolving role of natural products to overcome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biological Products; Cardiovascular Diseases; Humans; Inflammation; Neoplasms; Skin Diseases | 2019 |
A comprehensive comparative study on LSD1 in different cancers and tumor specific LSD1 inhibitors.
Topics: Carcinogenesis; Histone Demethylases; Humans; Neoplasms | 2022 |
Oncotherapeutic Application of Resveratrol-based Inorganic Nanoparticles.
Topics: Humans; Metal Nanoparticles; Neoplasms; Phytochemicals; Resveratrol | 2021 |
Chemo-Preventive Action of Resveratrol: Suppression of p53-A Molecular Targeting Approach.
Topics: Antineoplastic Agents, Phytogenic; Humans; Neoplasms; Resveratrol; Tumor Suppressor Protein p53 | 2021 |
Targeting of cancer cell death mechanisms by resveratrol: a review.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Humans; Neoplasms; Resveratrol | 2021 |
Potential Role of Natural Products to Combat Radiotherapy and Their Future Perspectives.
Topics: Berberine; Biological Products; Curcumin; Emodin; Genistein; Humans; Neoplasms; Pentacyclic Triterpenes; Radiation-Protective Agents; Radiation-Sensitizing Agents; Radiotherapy; Resveratrol; Sesquiterpenes; Triterpenes; Ursolic Acid; Vitamin D; Withanolides | 2021 |
The role of polyphenols in overcoming cancer drug resistance: a comprehensive review.
Topics: Antineoplastic Agents; Catechin; Curcumin; Drug Resistance, Neoplasm; Neoplasms; Polyphenols; Resveratrol | 2022 |
Resveratrol as a modulatory of apoptosis and autophagy in cancer therapy.
Topics: Apoptosis; Autophagy; Humans; Neoplasms; Resveratrol; Signal Transduction; Stilbenes | 2022 |
The science of resveratrol, formulation, pharmacokinetic barriers and its chemotherapeutic potential.
Topics: Biological Availability; Humans; Neoplasms; Pharmaceutical Preparations; Resveratrol; Stilbenes | 2022 |
Molecular Basis of Resveratrol-Induced Resensitization of Acquired Drug-Resistant Cancer Cells.
Topics: Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Humans; Neoplasms; Resveratrol | 2022 |
Potential Therapeutic Targets of Resveratrol, a Plant Polyphenol, and Its Role in the Therapy of Various Types of Cancer.
Topics: Antineoplastic Agents; Antioxidants; Humans; Neoplasms; Polyphenols; Resveratrol | 2022 |
Applications of resveratrol in the treatment of gastrointestinal cancer.
Topics: Antioxidants; Gastrointestinal Neoplasms; Humans; Neoplasms; Polyphenols; Resveratrol; Stilbenes | 2022 |
Anti-Cancer Effects of Dietary Polyphenols via ROS-Mediated Pathway with Their Modulation of MicroRNAs.
Topics: Animals; Catechin; MicroRNAs; Neoplasms; Polyphenols; Reactive Oxygen Species; Resveratrol; Tumor Microenvironment | 2022 |
Natural Radiosensitizers in Radiotherapy: Cancer Treatment by Combining Ionizing Radiation with Resveratrol.
Topics: Biological Products; Curcumin; Genistein; Humans; Neoplasms; Paclitaxel; Papaverine; Radiation Tolerance; Radiation-Sensitizing Agents; Radiation, Ionizing; Resveratrol | 2022 |
Polyphenols as Potent Epigenetics Agents for Cancer.
Topics: Animals; Antineoplastic Agents; Chromatin; Curcumin; DNA Methylation; Epigenesis, Genetic; Gallic Acid; Histones; Humans; Kaempferols; Mammals; MicroRNAs; Neoplasms; Polyphenols; Quercetin; Resveratrol | 2022 |
Resveratrol in Cancer Therapy: From Stimulation of Genomic Stability to Adjuvant Cancer Therapy: A Comprehensive Review.
Topics: Antineoplastic Agents; Antioxidants; Genomic Instability; Humans; Neoplasms; Resveratrol | 2023 |
Mechanism of Resveratrol-Induced Programmed Cell Death and New Drug Discovery against Cancer: A Review.
Topics: Antineoplastic Agents; Apoptosis; Drug Discovery; Humans; Neoplasms; Resveratrol; Stilbenes | 2022 |
Evidence for Multilevel Chemopreventive Activities of Natural Phenols from Functional Genomic Studies of Curcumin, Resveratrol, Genistein, Quercetin, and Luteolin.
Topics: Curcumin; Genistein; Genomics; Humans; Luteolin; Neoplasms; Phenols; Quercetin; Resveratrol; Tumor Suppressor Protein p53 | 2022 |
Immunoregulation by resveratrol; implications for normal tissue protection and tumour suppression.
Topics: Antineoplastic Agents; Humans; Immunity; Killer Cells, Natural; Neoplasms; Resveratrol | 2023 |
Co-administration of curcumin with other phytochemicals improves anticancer activity by regulating multiple molecular targets.
Topics: Curcumin; Humans; Neoplasms; Phytochemicals; Quercetin; Resveratrol | 2023 |
Substances of Natural Origin in Medicine: Plants vs. Cancer.
Topics: Anticarcinogenic Agents; Cell Death; Humans; Neoplasms; Resveratrol | 2023 |
Modulation of long non-coding RNAs by resveratrol as a potential therapeutic approach in cancer: A comprehensive review.
Topics: Epigenesis, Genetic; Humans; Neoplasms; Resveratrol; RNA, Long Noncoding | 2023 |
Role of Dietary Phytochemicals in Targeting Human miRNAs for Cancer Prevention and Treatment.
Topics: Carcinogenesis; Humans; MicroRNAs; Neoplasms; Phytochemicals; Resveratrol | 2023 |
Natural dimers of coumarin, chalcones, and resveratrol and the link between structure and pharmacology.
Topics: Antineoplastic Agents, Phytogenic; Biological Products; Chalcones; Coumarins; Dimerization; DNA Topoisomerases; Humans; Molecular Structure; Neoplasms; Resveratrol; Topoisomerase Inhibitors | 2019 |
Switching from Conventional to Nano-natural Phytochemicals to Prevent and Treat Cancers: Special Emphasis on Resveratrol.
Topics: Biological Availability; Humans; Nanoparticles; Neoplasms; Phytochemicals; Resveratrol | 2019 |
Resveratrol targeting the Wnt signaling pathway: A focus on therapeutic activities.
Topics: Animals; Antioxidants; Humans; Immunomodulation; Neoplasms; Resveratrol; Wnt Signaling Pathway | 2020 |
Resveratrol as an Adjuvant for Normal Tissues Protection and Tumor Sensitization.
Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Drug Resistance, Neoplasm; Humans; Molecular Targeted Therapy; Neoplasms; Oxidative Stress; Radiation-Protective Agents; Resveratrol | 2020 |
Tumor PD-L1 Induction by Resveratrol/Piceatannol May Function as a Search, Enhance, and Engage ("SEE") Signal to Facilitate the Elimination of "Cold, Non-Responsive" Low PD-L1-Expressing Tumors by PD-L1 Blockade.
Topics: Animals; Antineoplastic Agents; B7-H1 Antigen; Humans; Neoplasms; Resveratrol; Stilbenes | 2019 |
The Potential Use of Resveratrol for Cancer Prevention.
Topics: Animals; Antineoplastic Agents, Phytogenic; Chemoprevention; Clinical Studies as Topic; Disease Management; Disease Susceptibility; Drug Discovery; Drug Evaluation, Preclinical; Humans; Neoplasms; Resveratrol; Signal Transduction | 2019 |
Molecular mechanisms linking environmental toxicants to cancer development: Significance for protective interventions with polyphenols.
Topics: Anthocyanins; Humans; Neoplasms; Phytochemicals; Polyphenols; Resveratrol | 2022 |
Anticancer Potential of Resveratrol, β-Lapachone and Their Analogues.
Topics: Antineoplastic Agents; Humans; Inhibitory Concentration 50; Naphthoquinones; Neoplasms; Resveratrol; Tumor Suppressor Protein p53 | 2020 |
Natural products and phytochemical nanoformulations targeting mitochondria in oncotherapy: an updated review on resveratrol.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Drug Carriers; Glycolysis; Humans; Mitochondria; Mitochondrial Membranes; Nanoparticles; Neoplasms; NF-kappa B; Reactive Oxygen Species; Resveratrol; Signal Transduction; Sirtuins | 2020 |
Nanoencapsulated dietary polyphenols for cancer prevention and treatment: successes and challenges.
Topics: Animals; Catechin; Curcumin; Humans; Neoplasms; Polyphenols; Quercetin; Resveratrol | 2020 |
Resveratrol in Cancer Patients: From Bench to Bedside.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cardiovascular Diseases; Chemical Phenomena; Clinical Studies as Topic; Drug Evaluation, Preclinical; Drug Interactions; Humans; Neoplasms; Resveratrol; Structure-Activity Relationship; Translational Research, Biomedical; Treatment Outcome | 2020 |
Polyphenols as Caloric-Restriction Mimetics and Autophagy Inducers in Aging Research.
Topics: Aging; Animals; Apoptosis; Autophagy; Caloric Restriction; Cellular Senescence; Diabetes Mellitus; Dietary Supplements; Healthy Aging; Humans; Longevity; Mitochondria; Neoplasms; Neurodegenerative Diseases; Polyphenols; Protein Aggregation, Pathological; Resveratrol; Sirtuin 1 | 2020 |
A review of the chemopreventative and chemotherapeutic properties of the phytochemicals berberine, resveratrol and curcumin, and their influence on cell death via the pathways of apoptosis and autophagy.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Berberine; Curcumin; Humans; Neoplasms; Phytochemicals; Resveratrol | 2020 |
Resveratrol and other Stilbenes: Effects on Dysregulated Gene Expression in Cancers and Novel Delivery Systems.
Topics: Antineoplastic Agents, Phytogenic; Drug Delivery Systems; Gene Expression Regulation, Neoplastic; Humans; Liposomes; Molecular Structure; Nanoparticles; Neoplasms; Resveratrol; Stilbenes | 2021 |
Regulation of p27
Topics: Antineoplastic Agents, Phytogenic; Catechin; Cell Cycle; Cell Line, Tumor; Cell Nucleus; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinase Inhibitor p57; Cytoplasm; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Proteasome Endopeptidase Complex; Protein Domains; Proteolysis; Resveratrol | 2020 |
Resveratrol and Tumor Microenvironment: Mechanistic Basis and Therapeutic Targets.
Topics: Antineoplastic Agents; Cytokines; Humans; Neoplasms; Reactive Oxygen Species; Resveratrol; Tumor Microenvironment; Tumor-Associated Macrophages; Vascular Endothelial Growth Factor A | 2020 |
Optimum health and inhibition of cancer progression by microbiome and resveratrol.
Topics: Antioxidants; Disease Progression; Gastrointestinal Microbiome; Humans; Neoplasms; Resveratrol | 2021 |
Resveratrol as an Enhancer of Apoptosis in Cancer: A Mechanistic Review.
Topics: Antineoplastic Agents; Apoptosis; Humans; Neoplasms; Resveratrol | 2021 |
Chemotherapeutic efficacy of curcumin and resveratrol against cancer: Chemoprevention, chemoprotection, drug synergism and clinical pharmacokinetics.
Topics: Animals; Antineoplastic Agents, Phytogenic; Chemoprevention; Curcumin; Drug Synergism; Humans; Neoplasms; Phytochemicals; Resveratrol | 2021 |
Resveratrol-loaded nanomedicines for cancer applications.
Topics: Administration, Oral; Animals; Antioxidants; Biological Availability; Cell Line, Tumor; Delayed-Action Preparations; Drug Compounding; Drug Stability; Half-Life; Humans; Mice; Nanoparticle Drug Delivery System; Neoplasms; Resveratrol; Solubility; Xenograft Model Antitumor Assays | 2021 |
Resveratrol as Chemosensitizer Agent: State of Art and Future Perspectives.
Topics: Antineoplastic Agents, Phytogenic; Biological Products; Humans; Neoplasms; Resveratrol | 2021 |
Recent Advancements on Immunomodulatory Mechanisms of Resveratrol in Tumor Microenvironment.
Topics: Animals; Antioxidants; Humans; Immunomodulation; Neoplasms; Resveratrol; Tumor Microenvironment | 2021 |
Resveratrol for cancer therapy: Challenges and future perspectives.
Topics: Animals; Antineoplastic Agents; Humans; Neoplasms; Resveratrol; Signal Transduction | 2021 |
Boosting immune system against cancer by resveratrol.
Topics: Humans; Immunotherapy; Killer Cells, Natural; Neoplasms; Resveratrol; T-Lymphocytes, Regulatory | 2021 |
Resveratrol for targeting the tumor microenvironment and its interactions with cancer cells.
Topics: Cancer-Associated Fibroblasts; Cell Communication; Humans; Killer Cells, Natural; Neoplasms; Neoplastic Stem Cells; Resveratrol; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Tumor Hypoxia; Tumor Microenvironment | 2021 |
Natural Product-Based Hybrids as Potential Candidates for the Treatment of Cancer: Focus on Curcumin and Resveratrol.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biological Products; Curcumin; Drug Delivery Systems; Gold; Humans; Metal Nanoparticles; Neoplasms; Resveratrol; Stilbenes | 2021 |
Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective.
Topics: Antineoplastic Agents; Antioxidants; Biological Availability; Catechin; Curcumin; Drug Delivery Systems; Humans; Nanocomposites; Nanoparticles; Neoplasms; Polyphenols; Quercetin; Resveratrol; Stilbenes | 2017 |
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases.
Topics: Berberine; Cardiovascular Diseases; Curcumin; Gene Expression Regulation; Glycogen Synthase Kinase 3; Humans; Inflammation; Mechanistic Target of Rapamycin Complex 1; Neoplasms; Neurodegenerative Diseases; Osteoarthritis; Phosphatidylinositol 3-Kinases; Protective Agents; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Resveratrol; Signal Transduction; Stilbenes | 2017 |
Cancer Chemoprevention by Resveratrol: The p53 Tumor Suppressor Protein as a Promising Molecular Target.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biological Availability; Biomarkers, Tumor; Chemoprevention; Clinical Trials as Topic; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Outcome Assessment, Health Care; Resveratrol; Signal Transduction; Stilbenes; Tumor Suppressor Protein p53 | 2017 |
Childhood cancer chemotherapy-induced bone damage: pathobiology and protective effects of resveratrol and other nutraceuticals.
Topics: Antimetabolites, Antineoplastic; Bone Resorption; Cell Differentiation; Child; Dietary Supplements; Humans; Methotrexate; Neoplasms; Protective Agents; Resveratrol; Stilbenes | 2017 |
Nanoparticle formulations to enhance tumor targeting of poorly soluble polyphenols with potential anticancer properties.
Topics: Biological Availability; Curcumin; Drug Compounding; Humans; Nanoparticles; Neoplasms; Polyphenols; Quercetin; Resveratrol; Stilbenes | 2017 |
Identification of Antineoplastic Targets with Systems Approaches, Using Resveratrol as an In-Depth Case Study.
Topics: Animals; Antineoplastic Agents; Binding Sites; Drug Design; Drug Discovery; High-Throughput Screening Assays; Humans; Molecular Targeted Therapy; Neoplasms; Resveratrol; Systems Biology | 2017 |
Significance of Resveratrol in Clinical Management of Chronic Diseases.
Topics: Aging; Cardiovascular Diseases; Chronic Disease; Diabetes Mellitus; Dose-Response Relationship, Drug; Humans; Neoplasms; Obesity; Polyphenols; Resveratrol; Stilbenes | 2017 |
Therapeutic Implications of Autophagy Inducers in Immunological Disorders, Infection, and Cancer.
Topics: Adaptive Immunity; Animals; Autoimmune Diseases; Autophagy; Benzylisoquinolines; Cholecalciferol; Humans; Immune System Diseases; Immunity, Innate; Indoles; Infections; Isoquinolines; Lysosomes; Maprotiline; Metformin; Neoplasms; Phenols; Pyrroles; Resveratrol; Sirolimus; Spermidine; Stilbenes; Tetrahydroisoquinolines; Trehalose | 2017 |
Biological Mechanisms by Which Antiproliferative Actions of Resveratrol Are Minimized.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cell Transformation, Neoplastic; Humans; Neoplasms; Resveratrol; Signal Transduction; Stilbenes; Thyroid Hormones; Treatment Failure | 2017 |
Resveratrol and cancer treatment: updates.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Disease Progression; Humans; Neoplasms; Resveratrol; Signal Transduction; Stilbenes | 2017 |
Polyphenols in Food: Cancer Prevention and Apoptosis Induction.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Line, Tumor; Food; Humans; Hydroxybenzoates; Male; Neoplasms; Polyphenols; Resveratrol | 2018 |
A comprehensive review of the health perspectives of resveratrol.
Topics: Animals; Antineoplastic Agents; Humans; Neoplasms; Resveratrol; Stilbenes | 2017 |
The Role of Resveratrol in Cancer Therapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Neoplasms; Resveratrol; Stilbenes | 2017 |
Effect of resveratrol and pterostilbene on aging and longevity.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Cardiovascular Diseases; Cataract; Cellular Senescence; Humans; Inflammation; Longevity; Neoplasms; Neurodegenerative Diseases; NF-E2-Related Factor 2; Osteoporosis; Oxidative Stress; Resveratrol; Sirtuin 1; Stilbenes; Telomere Homeostasis | 2018 |
Chemoprevention by resveratrol and pterostilbene: Targeting on epigenetic regulation.
Topics: Anti-Inflammatory Agents; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Bone Diseases; Cardiovascular Diseases; Chemoprevention; DNA Methylation; Epigenesis, Genetic; Histones; Humans; MicroRNAs; Neoplasms; Neurodegenerative Diseases; Protein Processing, Post-Translational; Resveratrol; Stilbenes | 2018 |
Evaluation of Resveratrol in Cancer Patients and Experimental Models.
Topics: Animals; Antineoplastic Agents, Phytogenic; Evaluation Studies as Topic; Humans; Models, Theoretical; Neoplasms; Resveratrol | 2018 |
Regulation of Cell Signaling Pathways and miRNAs by Resveratrol in Different Cancers.
Topics: Animals; Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Gene Expression Regulation, Neoplastic; Hedgehog Proteins; Humans; MicroRNAs; Neoplasms; Receptors, Notch; Resveratrol; Signal Transduction; Smad Proteins; STAT Transcription Factors; Stilbenes; TNF-Related Apoptosis-Inducing Ligand; Transforming Growth Factor beta1; Treatment Outcome; Wnt Signaling Pathway; Zinc Finger Protein GLI1 | 2018 |
Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Inflammation; Mice; Neoplasms; Obesity; Rats; Respiratory Tract Diseases; Resveratrol; Stilbenes | 2018 |
Prevention from radiation damage by natural products.
Topics: Antioxidants; Ascorbic Acid; Curcumin; DNA Damage; Flavonoids; Humans; Lipid Peroxidation; Neoplasms; Phytochemicals; Plants; Polyphenols; Radiation Injuries; Radiation-Protective Agents; Radiotherapy; Reactive Oxygen Species; Resveratrol; Stilbenes | 2018 |
Resveratrol: from enhanced biosynthesis and bioavailability to multitargeting chronic diseases.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Biological Availability; Cardiovascular Diseases; Chronic Disease; Diabetes Mellitus; Drug Delivery Systems; Humans; Neoplasms; Obesity; Protein Biosynthesis; Resveratrol | 2019 |
Derivatives and Analogues of Resveratrol: Recent Advances in Structural Modification.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antioxidants; Free Radicals; Humans; Molecular Structure; Neoplasms; Resveratrol | 2019 |
Health benefits of resveratrol: Evidence from clinical studies.
Topics: Animals; Antioxidants; Diabetes Mellitus; Humans; Metabolic Syndrome; Neoplasms; Obesity; Resveratrol | 2019 |
Resveratrol as a Tumor-Suppressive Nutraceutical Modulating Tumor Microenvironment and Malignant Behaviors of Cancer.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Biomarkers; Dietary Supplements; Humans; Neoplasms; Neovascularization, Pathologic; Resveratrol; Signal Transduction; Stress, Physiological; Tumor Microenvironment | 2019 |
The immunomodulatory potential of natural compounds in tumor-bearing mice and humans.
Topics: Animals; beta-Glucans; Carotenoids; Catechin; Curcumin; Humans; Immune System; Immunologic Factors; Killer Cells, Natural; Mice; Neoplasms; Resveratrol; T-Lymphocytes; Tretinoin; Tumor Microenvironment | 2019 |
Health benefits of resveratrol administration.
Topics: Aging; Animals; Anti-Inflammatory Agents; Humans; Neoplasms; Neuroprotection; Resveratrol | 2019 |
Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology.
Topics: Animals; Antineoplastic Agents; Cardiotonic Agents; Cardiovascular Diseases; Cell Line, Tumor; Humans; Medical Oncology; Mice; Neoplasms; Resveratrol | 2019 |
Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases.
Topics: Antineoplastic Agents, Phytogenic; Chronic Disease; Gene Expression Regulation, Neoplastic; Humans; Molecular Targeted Therapy; Neoplasms; Phytochemicals; Resveratrol; RNA, Long Noncoding | 2019 |
Overview of Cellular Mechanisms and Signaling Pathways of Piceatannol.
Topics: Animals; Cardiovascular Diseases; Cell Cycle; Fabaceae; Humans; Neoplasms; Neuroprotection; Phytotherapy; Protein Kinase Inhibitors; Resveratrol; Signal Transduction; Stilbenes | 2020 |
The Effect of Resveratrol on Cellular Senescence in Normal and Cancer Cells: Focusing on Cancer and Age-Related Diseases.
Topics: Aging; Animals; Cellular Senescence; Humans; Neoplasms; Neuroprotective Agents; Resveratrol; Skin | 2019 |
Noncoding RNAs as Molecular Targets of Resveratrol Underlying Its Anticancer Effects.
Topics: Animals; Antineoplastic Agents, Phytogenic; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Molecular Targeted Therapy; Neoplasms; Resveratrol; RNA, Long Noncoding | 2019 |
Targeting Cancer Via Resveratrol-Loaded Nanoparticles Administration: Focusing on In Vivo Evidence.
Topics: Animals; Antineoplastic Agents; Drug Carriers; Drug Stability; Humans; Nanoparticles; Nanotechnology; Neoplasms; Resveratrol; Solubility | 2019 |
How efficient is resveratrol as an antioxidant of the Mediterranean diet, towards alterations during the aging process?
Topics: Animals; Antioxidants; Cardiovascular Diseases; Diet, Mediterranean; Healthy Aging; Humans; Neoplasms; Resveratrol | 2019 |
Resveratrol Action on Lipid Metabolism in Cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cholesterol; Clinical Trials as Topic; Humans; Lipid Metabolism; Lipid Peroxidation; Metabolic Networks and Pathways; Neoplasms; Reactive Oxygen Species; Resveratrol; Treatment Outcome | 2019 |
Stilbene Compounds Inhibit Tumor Growth by the Induction of Cellular Senescence and the Inhibition of Telomerase Activity.
Topics: Animals; Antineoplastic Agents; Cellular Senescence; Humans; Neoplasms; Resveratrol; Stilbenes; Telomerase | 2019 |
Glut 1 in Cancer Cells and the Inhibitory Action of Resveratrol as A Potential Therapeutic Strategy.
Topics: Animals; Glucose; Glucose Transporter Type 1; Humans; Neoplasms; Resveratrol | 2019 |
Effects of dietary phytophenols on the expression of microRNAs involved in mammalian cell homeostasis.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Cell Differentiation; Cell Physiological Phenomena; Diet; Dietary Fiber; Fruit; Gene Expression; Homeostasis; Humans; Inflammation; MicroRNAs; Neoplasms; Phenols; Plants; Polyphenols; Resveratrol; Signal Transduction; Stilbenes; Vegetables | 2013 |
Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Glucose; Humans; Lipid Metabolism; Neoplasms; Resveratrol; Stilbenes | 2014 |
Regulating miRNA by natural agents as a new strategy for cancer treatment.
Topics: Animals; Antineoplastic Agents; Carotenoids; Catechin; Curcumin; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Lycopene; MicroRNAs; Molecular Targeted Therapy; Neoplasms; Neoplastic Stem Cells; Resveratrol; Stilbenes | 2013 |
What is new for resveratrol? Is a new set of recommendations necessary?
Topics: Animals; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Neoplasms; Practice Guidelines as Topic; Resveratrol; Stilbenes | 2013 |
Resveratrol in the management of human cancer: how strong is the clinical evidence?
Topics: Animals; Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Disease Management; Dose-Response Relationship, Drug; Humans; Neoplasms; Resveratrol; Stilbenes | 2013 |
Resveratrol analogs: promising chemopreventive agents.
Topics: Animals; Antineoplastic Agents; Chemoprevention; Humans; Neoplasms; Resveratrol; Stilbenes; Structure-Activity Relationship | 2013 |
Importance of lipid microdomains, rafts, in absorption, delivery, and biological effects of resveratrol.
Topics: Absorption; Animals; Apoptosis; Drug Delivery Systems; Humans; Lipid Metabolism; Membrane Microdomains; Neoplasms; Resveratrol; Stilbenes; Treatment Outcome | 2013 |
Resveratrol-based combinatorial strategies for cancer management.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combinatorial Chemistry Techniques; Disease Management; Humans; Neoplasms; Resveratrol; Stilbenes | 2013 |
Resveratrol: from basic studies to bedside.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biomedical Research; Cellular Senescence; Clinical Trials as Topic; Humans; Neoplasms; Resveratrol; Stilbenes | 2014 |
Toxicological and pharmacological concerns on oxidative stress and related diseases.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Benzopyrans; Carbazoles; Carvedilol; Diabetes Mellitus; Disease Models, Animal; Ethanolamines; Humans; Hydrogen Peroxide; Inflammatory Bowel Diseases; Nebivolol; Neoplasms; Neurodegenerative Diseases; Osteoporosis; Oxidative Stress; Propanolamines; Reactive Oxygen Species; Resveratrol; Stilbenes; Vascular Diseases | 2013 |
Resveratrol in peanuts.
Topics: Alzheimer Disease; Antioxidants; Arachis; Biological Availability; Cardiovascular Diseases; Diet; Humans; Neoplasms; Resveratrol; Stilbenes | 2014 |
Synergistic effect of resveratrol and radiotherapy in control of cancers.
Topics: Animals; Apoptosis; Cell Proliferation; Chemoradiotherapy; Humans; Neoplasms; Radiation Tolerance; Radiation-Sensitizing Agents; Resveratrol; Stilbenes | 2013 |
Resveratrol and cancer: focus on in vivo evidence.
Topics: Animals; Antineoplastic Agents; Humans; Neoplasms; Resveratrol; Stilbenes | 2014 |
Antagonistic role of natural compounds in mTOR-mediated metabolic reprogramming.
Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Cell Transformation, Neoplastic; Cellular Reprogramming; Curcumin; Humans; Neoplasms; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Quercetin; Resveratrol; Signal Transduction; Stilbenes; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53 | 2015 |
Could resveratrol be a useful drug for the treatment of malignant hemopathies?
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Drug Therapy, Combination; Hematologic Neoplasms; Humans; Neoplasms; Patents as Topic; Resveratrol; Stilbenes | 2014 |
AMPK at the nexus of energetics and aging.
Topics: Aging; AMP-Activated Protein Kinases; Animals; Aspirin; Energy Metabolism; Humans; Metabolic Diseases; Metformin; Mitochondria; Neoplasms; Resveratrol; Stilbenes | 2014 |
Resveratrol oligomers for the prevention and treatment of cancers.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Humans; Neoplasms; Polymers; Resveratrol; Stilbenes | 2014 |
From French Paradox to cancer treatment: anti-cancer activities and mechanisms of resveratrol.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Proliferation; France; Humans; Neoplasms; Resveratrol; Signal Transduction; Stilbenes; Wine | 2014 |
Targeting cancer with nano-bullets: curcumin, EGCG, resveratrol and quercetin on flying carpets.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Antioxidants; Apoptosis; Catechin; Cell Proliferation; Cell Transformation, Neoplastic; Curcumin; Drug Carriers; Humans; Lactic Acid; Mice; Nanoparticles; Neoplasms; Phytochemicals; Polyglycolic Acid; Polyhydroxyethyl Methacrylate; Polylactic Acid-Polyglycolic Acid Copolymer; Quercetin; Resveratrol; Silicon Dioxide; Stilbenes; Xenograft Model Antitumor Assays | 2014 |
Mediterranean Way of Drinking and Longevity.
Topics: Alcohol Drinking; Cardiovascular Diseases; Diet, Mediterranean; Female; Flavonols; Humans; Liver Cirrhosis; Longevity; Male; Mediterranean Region; Neoplasms; Phenols; Resveratrol; Risk Factors; Sex Factors; Sirtuins; Stilbenes; Wine | 2016 |
The role of phytochemicals as micronutrients in health and disease.
Topics: Cardiovascular Diseases; Catechin; Clinical Trials as Topic; Curcuma; Curcumin; Dementia; Diabetes Mellitus; Humans; Micronutrients; Neoplasms; Phytochemicals; Plant Extracts; Resveratrol; Stilbenes; Tea; Vitis; Wine | 2014 |
Regulation of microRNAs by natural agents: new strategies in cancer therapies.
Topics: Antineoplastic Agents; Biological Products; Biomarkers, Tumor; Catechin; Curcumin; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Neoplasms; Resveratrol; RNA Stability; Stilbenes | 2014 |
Resveratrol-mediated reversal of tumor multi-drug resistance.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Neoplasms; Resveratrol; Stilbenes | 2014 |
Resveratrol and its oligomers: modulation of sphingolipid metabolism and signaling in disease.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Binding Sites; Cardiovascular Diseases; Drug Discovery; Humans; Molecular Docking Simulation; Molecular Structure; Neoplasms; Neurodegenerative Diseases; Resveratrol; Signal Transduction; Sphingolipids; Stilbenes | 2014 |
Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer.
Topics: Acetophenones; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Benzopyrans; Cell Line, Tumor; Curcumin; Gene Expression Regulation, Neoplastic; Genistein; Humans; Membrane Proteins; Neoplasms; Polyphenols; Quercetin; Resveratrol; Signal Transduction; Stilbenes | 2014 |
Resveratrol and cancer: Challenges for clinical translation.
Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Humans; Neoplasms; Resveratrol; Stilbenes; Translational Research, Biomedical | 2015 |
Common pathways in health benefit properties of RSV in cardiovascular diseases, cancers and degenerative pathologies.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Humans; Neoplasms; Neurodegenerative Diseases; Polyphenols; Resveratrol; Signal Transduction; Stilbenes; Wine | 2015 |
A Review: Phytochemicals Targeting JAK/STAT Signaling and IDO Expression in Cancer.
Topics: Animals; Catechin; Cell Proliferation; Cucurbitacins; Curcumin; Disease Models, Animal; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Janus Kinases; Neoplasms; Phytochemicals; Resveratrol; Signal Transduction; STAT Transcription Factors; Stilbenes | 2015 |
Metabolomics of cancer cell cultures to assess the effects of dietary phytochemicals.
Topics: Cell Line, Tumor; Curcumin; Humans; Magnetic Resonance Spectroscopy; Metabolome; Metabolomics; Neoplasms; Phytochemicals; Resveratrol; Stilbenes | 2017 |
Resveratrol nanoformulation for cancer prevention and therapy.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Chemistry, Pharmaceutical; Humans; Nanocapsules; Neoplasms; Resveratrol; Stilbenes | 2015 |
Resveratrol as a novel treatment for diseases with mTOR pathway hyperactivation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Humans; Molecular Targeted Therapy; Neoplasms; Resveratrol; Signal Transduction; Stilbenes; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2015 |
Assessing the aftermath of an alcohol-fueled weekend: Alcohol-induced DNA damage and faulty repairs may raise the risk of certain cancers, but resveratrol could provide some relief.
Topics: Alcohol-Related Disorders; Anticarcinogenic Agents; Binge Drinking; DNA Damage; Female; Humans; Male; Neoplasms; Prognosis; Resveratrol; Risk Assessment; Stilbenes; Treatment Outcome | 2015 |
Enhancing Activity of Anticancer Drugs in Multidrug Resistant Tumors by Modulating P-Glycoprotein through Dietary Nutraceuticals.
Topics: Abietanes; Alkaloids; Allyl Compounds; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Benzodioxoles; beta Carotene; Biflavonoids; Capsaicin; Catechin; Catechols; Curcumin; Dietary Supplements; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Fatty Alcohols; Furocoumarins; Humans; Indoles; Limonins; Neoplasms; Phytotherapy; Piperidines; Polyunsaturated Alkamides; Proanthocyanidins; Quercetin; Resveratrol; Stilbenes; Sulfides; Tea; Triterpenes; Xanthophylls | 2015 |
Natural polyphenols based new therapeutic avenues for advanced biomedical applications.
Topics: Aging; Animals; Anti-Infective Agents; Antioxidants; Catechin; Food Hypersensitivity; Humans; Models, Biological; Neoplasms; Polyphenols; Renal Insufficiency; Resveratrol; Stilbenes; Stroke | 2015 |
Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive Agents.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biological Products; Cancer Vaccines; Chemoprevention; Cytarabine; Dietary Supplements; Humans; Neoplasms; Phytochemicals; Resveratrol; Stilbenes | 2016 |
A Comprehensive Review on the Chemotherapeutic Potential of Piceatannol for Cancer Treatment, with Mechanistic Insights.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Humans; Neoplasms; Resveratrol; Stilbenes | 2016 |
Role of Natural Stilbenes in the Prevention of Cancer.
Topics: Animals; Chemoprevention; Clinical Trials as Topic; Humans; Neoplasms; Resveratrol; Stilbenes; Structure-Activity Relationship | 2016 |
Resveratrol and the mitochondria: From triggering the intrinsic apoptotic pathway to inducing mitochondrial biogenesis, a mechanistic view.
Topics: Animals; Apoptosis; Humans; Mitochondria; Neoplasms; Neurodegenerative Diseases; Resveratrol; Stilbenes | 2016 |
Combination chemoprevention with grape antioxidants.
Topics: Animals; Anthocyanins; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Catechin; Cell Line, Tumor; Chemoprevention; Disease Models, Animal; Humans; Kaempferols; Neoplasms; Plant Extracts; Polyphenols; Quercetin; Resveratrol; Stilbenes; Vitis | 2016 |
Impact of nanotechnology on the delivery of natural products for cancer prevention and therapy.
Topics: Animals; Anticarcinogenic Agents; Biological Products; Catechin; Cell Line, Tumor; Chemoprevention; Curcumin; Disease Models, Animal; Humans; Nanoparticles; Nanotechnology; Neoplasms; Resveratrol; Stilbenes | 2016 |
Targeting cancer stem-like cells using dietary-derived agents - Where are we now?
Topics: Animals; Anticarcinogenic Agents; Catechin; Cell Line, Tumor; Curcumin; Diet; Disease Models, Animal; Flavonoids; Humans; Isothiocyanates; Neoplasms; Neoplastic Stem Cells; Randomized Controlled Trials as Topic; Resveratrol; Stilbenes; Sulfoxides; Vitamin A | 2016 |
Nutritional immunology: function of natural killer cells and their modulation by resveratrol for cancer prevention and treatment.
Topics: Antineoplastic Agents, Phytogenic; Diet; Humans; Killer Cells, Natural; Neoplasms; Nutritional Physiological Phenomena; Plants, Edible; Resveratrol; Stilbenes | 2016 |
The Use of Stilbene Scaffold in Medicinal Chemistry and Multi- Target Drug Design.
Topics: Alzheimer Disease; Antineoplastic Agents, Phytogenic; Bibenzyls; Chemistry, Pharmaceutical; Drug Design; Humans; Neoplasms; Resveratrol; Stilbenes; Structure-Activity Relationship | 2016 |
Roles of Dietary Phytoestrogens on the Regulation of Epithelial-Mesenchymal Transition in Diverse Cancer Metastasis.
Topics: Anticarcinogenic Agents; Antineoplastic Agents; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Genistein; Humans; Indoles; Kaempferols; Neoplasm Metastasis; Neoplasms; Phytoestrogens; Resveratrol; Stilbenes | 2016 |
Challenges in Analyzing the Biological Effects of Resveratrol.
Topics: Alzheimer Disease; Animals; Antioxidants; Biological Availability; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Humans; Metabolic Diseases; Neoplasms; Phytochemicals; Randomized Controlled Trials as Topic; Resveratrol; Stilbenes | 2016 |
Small Molecules as SIRT Modulators.
Topics: Humans; Imidazoles; Naphthalenes; Neoplasms; Neurodegenerative Diseases; Polyphenols; Pyrimidinones; Resveratrol; Sirtuins; Small Molecule Libraries; Stilbenes; Triterpenes | 2018 |
Polyphenol compounds and PKC signaling.
Topics: Curcumin; Humans; Neoplasms; Polyphenols; Protein Kinase C; Resveratrol; Signal Transduction; Stilbenes | 2016 |
Role of angiogenic factors of herbal origin in regulation of molecular pathways that control tumor angiogenesis.
Topics: Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Artemisinins; Catechin; Cell Proliferation; Curcumin; Humans; Neoplasms; Neovascularization, Pathologic; Plant Extracts; Resveratrol; Stilbenes; Triterpenes | 2016 |
Anticancer Efficacy of Polyphenols and Their Combinations.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; Biological Availability; Catechin; Cell Line, Tumor; Cell Proliferation; Curcumin; Disease Models, Animal; Humans; Micronutrients; Neoplasms; Plant Extracts; Polyphenols; Quercetin; Resveratrol; Stilbenes; Tea | 2016 |
Synergistic Anticancer Effect of Tocotrienol Combined with Chemotherapeutic Agents or Dietary Components: A Review.
Topics: Antineoplastic Agents; Catechin; Coumaric Acids; Dietary Supplements; Dioxoles; Drug Synergism; Drug Therapy, Combination; Humans; Lignans; Neoplasms; Resveratrol; Stilbenes; Tocotrienols | 2016 |
Unraveling the Anticancer Effect of Curcumin and Resveratrol.
Topics: Animals; Antineoplastic Agents, Phytogenic; Curcumin; Humans; Neoplasms; Resveratrol; Stilbenes | 2016 |
The paradoxical pro- and antiangiogenic actions of resveratrol: therapeutic applications in cancer and diabetes.
Topics: Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Diabetes Mellitus; Dose-Response Relationship, Drug; Humans; Neoplasms; Resveratrol; Stilbenes | 2016 |
Anti-metastatic potential of resveratrol and its metabolites by the inhibition of epithelial-mesenchymal transition, migration, and invasion of malignant cancer cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Movement; Epithelial-Mesenchymal Transition; Fruit; Humans; Neoplasm Invasiveness; Neoplasms; Phytotherapy; Plant Extracts; Resveratrol; Stilbenes | 2016 |
Resveratrol as an anti-cancer agent: A review.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Cell Line, Tumor; Disease Models, Animal; Fruit; Humans; Neoplasms; Phytoalexins; Phytochemicals; Resveratrol; Sesquiterpenes; Stilbenes; Vitis | 2018 |
Patent Survey of Resveratrol, Taxol, Podophyllotoxin, Withanolides and Their Derivatives Used in Anticancer Therapy.
Topics: Humans; Neoplasms; Paclitaxel; Patents as Topic; Podophyllotoxin; Resveratrol; Stilbenes; Withanolides | 2017 |
Targeting miRNAs by polyphenols: Novel therapeutic strategy for cancer.
Topics: Catechin; Curcumin; Gene Expression Regulation, Neoplastic; Genistein; Humans; MicroRNAs; Neoplasms; Polyphenols; Resveratrol; Signal Transduction; Stilbenes | 2017 |
Cancer chemoprevention - selected molecular mechanisms.
Topics: Anticarcinogenic Agents; Apoptosis; Catechols; Chemoprevention; Curcumin; Fatty Alcohols; Humans; Neoplasms; Neovascularization, Pathologic; Resveratrol; Signal Transduction; Stilbenes | 2017 |
Implications of Resveratrol on Glucose Uptake and Metabolism.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biological Transport; Carbohydrate Metabolism; Diabetes Mellitus, Type 2; Drug Synergism; Glucose; Homeostasis; Humans; Neoplasms; Polyphenols; Resveratrol; Signal Transduction; Stilbenes | 2017 |
Resveratrol and Brain Mitochondria: a Review.
Topics: Aging; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Antioxidants; Brain; Humans; Mitochondria; Neoplasms; Neurodegenerative Diseases; Resveratrol | 2018 |
Molecular mechanism of apoptosis induction by resveratrol, a natural cancer chemopreventive agent.
Topics: Anticarcinogenic Agents; Apoptosis; Biological Products; Chemoprevention; Humans; Neoplasms; Resveratrol; Signal Transduction; Stilbenes | 2008 |
Cancer chemoprevention and mitochondria: targeting apoptosis in transformed cells via the disruption of mitochondrial bioenergetics/redox state.
Topics: Animals; Apoptosis; Capsaicin; Catechin; Chemoprevention; Disease Models, Animal; Humans; Mitochondrial Membranes; Neoplasms; Permeability; Reactive Oxygen Species; Resveratrol; Stilbenes; Tea | 2009 |
Resveratrol and chemoprevention.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Cardiovascular Diseases; Drug Evaluation, Preclinical; Gene Expression Regulation; Humans; Neoplasms; Neoplasms, Hormone-Dependent; Phytoestrogens; Resveratrol; Signal Transduction; Stilbenes | 2009 |
Cellular signaling perturbation by natural products.
Topics: Antineoplastic Agents; Carotenoids; Catechin; Curcumin; Humans; Indoles; Isoflavones; Lycopene; Neoplasms; Resveratrol; Signal Transduction; Stilbenes | 2009 |
Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials.
Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Humans; Neoplasms; Resveratrol; Stilbenes | 2009 |
The pro-apoptotic action of stilbene-induced COX-2 in cancer cells: convergence with the anti-apoptotic effect of thyroid hormone.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Cell Proliferation; Cyclooxygenase 2; Cytokines; Enzyme Inhibitors; Humans; Neoplasms; Protein Kinases; Resveratrol; Signal Transduction; Stilbenes; Thyroid Hormones | 2009 |
Wine, resveratrol and health: a review.
Topics: Anticoagulants; Antineoplastic Agents, Phytogenic; Biological Availability; Cardiovascular Agents; Diet, Mediterranean; Humans; Lipid Metabolism; Neoplasms; Protective Agents; Resveratrol; Stilbenes; Vitis; Wine | 2009 |
Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms.
Topics: Anticarcinogenic Agents; Breast Neoplasms; Cathepsins; Cell Cycle; Cell Division; Female; Humans; Inflammation; Leukemia; Lymphoma; Male; Neoplasms; Prostatic Neoplasms; Resveratrol; Safety; Stilbenes; Transcription Factors | 2009 |
NAD(+) -dependent histone deacetylases (sirtuins) as novel therapeutic targets.
Topics: Animals; Epigenesis, Genetic; HIV Infections; Humans; Inhibitory Concentration 50; Models, Chemical; NAD; Neoplasms; Niacinamide; Protein Binding; Resveratrol; Signal Transduction; Silent Information Regulator Proteins, Saccharomyces cerevisiae; Sirtuin 2; Sirtuins; Stilbenes | 2010 |
Biochemical effects of SIRT1 activators.
Topics: Animals; Cardiotonic Agents; Energy Metabolism; Enzyme Activation; Heterocyclic Compounds, 4 or More Rings; Humans; Insulin Resistance; Learning; Longevity; Memory; Mice; Models, Biological; NAD; Neoplasms; Niacinamide; O-Acetyl-ADP-Ribose; Resveratrol; Silent Information Regulator Proteins, Saccharomyces cerevisiae; Sirtuin 1; Stilbenes | 2010 |
Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Antioxidants; Breast Neoplasms; DNA Adducts; Estrogens; Female; Humans; Male; Neoplasms; Resveratrol; Stilbenes | 2010 |
[Contemporary view of plant antioxidants role in prevention of civilization diseases].
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Chronic Disease; Dietary Supplements; Flavonoids; Health Promotion; Humans; Neoplasms; Phenols; Phytotherapy; Plant Extracts; Polyphenols; Resveratrol; Stilbenes | 2009 |
Resveratrol mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for chemoprevention of cancer.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Chemoprevention; Copper; DNA Damage; Humans; Lymphocytes; Neoplasms; Resveratrol; Stilbenes | 2010 |
Resveratrol and resveratrol analogues--structure-activity relationship.
Topics: Animals; Antineoplastic Agents; Free Radical Scavengers; Humans; Neoplasms; Resveratrol; Stilbenes; Structure-Activity Relationship | 2010 |
Fighting cancer with red wine? Molecular mechanisms of resveratrol.
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Biological Availability; Humans; Neoplasms; Resveratrol; Stilbenes; Wine | 2009 |
Modulation of apoptosis by natural products for cancer therapy.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Betulinic Acid; Clinical Trials as Topic; Gossypol; Humans; Mitochondria; Neoplasms; Pentacyclic Triterpenes; Reactive Oxygen Species; Resveratrol; Signal Transduction; Stilbenes; Triterpenes; Vitamin E | 2010 |
[Chemopreventive and chemotherapeutic effect of trans-resveratrol and its analogues in cancer].
Topics: Animals; Antineoplastic Agents, Phytogenic; Humans; Neoplasms; Resveratrol; Stilbenes | 2010 |
Resveratrol and derivatives for the prevention and treatment of cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Humans; Molecular Structure; Neoplasms; Resveratrol; Stilbenes | 2010 |
Resveratrol. Monograph.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Evidence-Based Medicine; Humans; Inflammation; Metabolic Syndrome; Neoplasms; Phytotherapy; Protective Agents; Resveratrol; Stilbenes | 2010 |
Potential of the dietary antioxidants resveratrol and curcumin in prevention and treatment of hematologic malignancies.
Topics: Antioxidants; Apoptosis; Cell Cycle; Cell Proliferation; Clinical Trials as Topic; Curcumin; Diet; Hematologic Neoplasms; Humans; Molecular Structure; Neoplasms; Oxidative Stress; Reactive Oxygen Species; Resveratrol; Stilbenes | 2010 |
A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 1.
Topics: Aging; Biological Availability; Cardiovascular Diseases; Enzyme Activators; Humans; Learning; Longevity; Memory; Neoplasms; Nervous System Diseases; Obesity; Phenols; Resveratrol; Sirtuins; Stilbenes | 2010 |
A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 2.
Topics: Aging; Biological Availability; Cardiovascular Diseases; Enzyme Activators; Humans; Longevity; Neoplasms; Nervous System Diseases; Obesity; Phenols; Resveratrol; Sirtuins; Stilbenes | 2010 |
Resveratrol and cellular mechanisms of cancer prevention.
Topics: Animals; Antineoplastic Agents, Phytogenic; Humans; Neoplasms; Resveratrol; Signal Transduction; Stilbenes | 2011 |
Chemoprevention in experimental animals.
Topics: Animals; Antineoplastic Agents, Phytogenic; Chemoprevention; Clinical Trials as Topic; Disease Models, Animal; Humans; Neoplasms; Resveratrol; Stilbenes | 2011 |
Chemopreventive effects of resveratrol and resveratrol derivatives.
Topics: Animals; Antineoplastic Agents, Phytogenic; Chemoprevention; Humans; Neoplasms; Resveratrol; Stilbenes; Structure-Activity Relationship | 2011 |
The phenomenon of resveratrol: redefining the virtues of promiscuity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cassia; Drug Delivery Systems; Humans; Neoplasms; Phytotherapy; Plant Extracts; Resveratrol; Stilbenes | 2011 |
Resveratrol in cancer management: where are we and where we go from here?
Topics: Animals; Chemoprevention; Disease Management; Humans; Neoplasms; Resveratrol; Stilbenes | 2011 |
Chemosensitization of tumors by resveratrol.
Topics: Animals; Antineoplastic Agents, Phytogenic; Drug Resistance, Neoplasm; Fruit; Humans; Neoplasms; Resveratrol; Stilbenes; Vegetables | 2011 |
Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Catechin; Clinical Trials as Topic; Curcuma; Curcumin; Diet; Disease Models, Animal; Fruit; Genistein; Humans; Neoplasms; Resveratrol; Signal Transduction; Silymarin; Stilbenes; United States; Vegetables | 2011 |
Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds.
Topics: Alkaloids; Animals; Anticarcinogenic Agents; Benzodioxoles; beta Catenin; Carotenoids; Catechin; Cell Differentiation; Cell Proliferation; Cholecalciferol; Curcumin; Diet; Humans; Isoflavones; Isothiocyanates; Lycopene; Neoplasms; Neoplastic Stem Cells; Piperidines; Polyunsaturated Alkamides; Resveratrol; Signal Transduction; Stilbenes; Sulfoxides; Thiocyanates; Wnt Proteins | 2011 |
Phytochemicals resveratrol and sulforaphane as potential agents for enhancing the anti-tumor activities of conventional cancer therapies.
Topics: Animals; Antineoplastic Agents, Phytogenic; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Isothiocyanates; Neoplasms; Resveratrol; Stilbenes; Sulfoxides; Thiocyanates | 2012 |
Epigenetic diet: impact on the epigenome and cancer.
Topics: Anticarcinogenic Agents; Catechin; Curcumin; Diet; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Epigenesis, Genetic; Epigenomics; Genistein; Histones; Humans; Isothiocyanates; MicroRNAs; Neoplasms; Polyphenols; Resveratrol; Stilbenes; Tea | 2011 |
Phytochemicals in cancer prevention and therapy: truth or dare?
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Carotenoids; Catechin; Curcumin; Genistein; Humans; Isothiocyanates; Lycopene; Neoplasms; Resveratrol; Stilbenes | 2010 |
Resveratrol in human cancer chemoprevention--choosing the 'right' dose.
Topics: Animals; Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Neoplasms; Resveratrol; Stilbenes | 2012 |
Old wine in a new bottle: the Warburg effect and anticancer mechanisms of resveratrol.
Topics: Animals; Copper; Glycolysis; Humans; Hydrogen-Ion Concentration; Neoplasms; Reactive Oxygen Species; Resveratrol; Stilbenes | 2012 |
Regulation of cell death and survival by resveratrol: implications for cancer therapy.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Biological Products; Cell Death; Cell Proliferation; Cell Survival; Humans; Neoplasms; Resveratrol; Stilbenes | 2012 |
Resveratrol in cancer: cellular and mitochondrial consequences of proton transport inhibition.
Topics: Antineoplastic Agents; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Proton-Translocating ATPases; Resveratrol; Stilbenes | 2012 |
Resveratrol: potential as anticancer agent.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Fallopia japonica; Humans; Neoplasms; Outcome Assessment, Health Care; Phytotherapy; Plant Extracts; Resveratrol; Stilbenes; Vitis; Wine | 2012 |
[Metabolic homeostasis as the cornerstone of aging].
Topics: Aging; Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Caloric Restriction; Cell Transformation, Neoplastic; Drosophila melanogaster; Energy Metabolism; Homeostasis; Humans; Insulin; Insulin-Like Growth Factor I; Longevity; Membrane Transport Proteins; Mice; Models, Biological; Neoplasms; Protein Kinases; Resveratrol; Signal Transduction; Stilbenes; TOR Serine-Threonine Kinases | 2012 |
The anticancer effects of resveratrol: modulation of transcription factors.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Humans; Neoplasms; NF-E2-Related Factor 2; Receptors, Aryl Hydrocarbon; Resveratrol; Signal Transduction; Stilbenes; Transcription Factors | 2012 |
Control of MicroRNA expression as a new way for resveratrol to deliver its beneficial effects.
Topics: Animals; Gene Expression Regulation; Humans; MicroRNAs; Neoplasms; Plant Extracts; Resveratrol; Stilbenes; Vitis | 2012 |
[Resveratrol--phytophenol with wide activity].
Topics: Adipose Tissue; Animals; Anti-Inflammatory Agents; Atherosclerosis; Cardiovascular Diseases; Chemoprevention; Glucose; Humans; Longevity; Neoplasms; Neurodegenerative Diseases; Resveratrol; Stilbenes | 2012 |
Glucan–resveratrol–vitamin C combination offers protection against toxic agents.
Topics: Animals; Ascorbic Acid; Drug Combinations; Environmental Pollutants; Glucans; Humans; Immune System; Immunity, Cellular; Immunity, Humoral; Neoplasms; Protective Agents; Resveratrol; Stilbenes; Thimerosal | 2012 |
Energy restriction: stepping stones towards cancer therapy.
Topics: AMP-Activated Protein Kinase Kinases; Antineoplastic Agents; Energy Metabolism; Enzyme Inhibitors; Hexokinase; Humans; Molecular Targeted Therapy; Neoplasms; Protein Kinases; Resveratrol; Stilbenes; Thiazolidinediones | 2012 |
Targeting mTOR: evaluating the therapeutic potential of resveratrol for cancer treatment.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Antioxidants; Humans; Molecular Targeted Therapy; Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes; TOR Serine-Threonine Kinases | 2013 |
Resveratrol and cancer treatment: is hormesis a yet unsolved matter?
Topics: Animals; Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Drug; Hormesis; Humans; Neoplasms; Resveratrol; Stilbenes | 2013 |
Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer.
Topics: Antioxidants; Cardiovascular Diseases; Carotenoids; Chronic Disease; Dietary Fiber; Estrogens, Non-Steroidal; Food; Humans; Isoflavones; Isothiocyanates; Lycopene; Monoterpenes; Neoplasms; Olive Oil; Phenols; Phytoestrogens; Phytosterols; Plant Oils; Plant Preparations; Resveratrol; Stilbenes; Tea | 2002 |
Structural concepts in cancer prevention.
Topics: Anticarcinogenic Agents; Chemoprevention; Clinical Trials as Topic; Female; Humans; Male; Mass Screening; Neoplasms; Prognosis; Resveratrol; Risk Assessment; Sensitivity and Specificity; Stilbenes; Structure-Activity Relationship | 2002 |
The basis for the chemopreventive action of resveratrol.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cardiovascular Diseases; Humans; Neoplasms; Resveratrol; Stilbenes | 2002 |
Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Humans; Neoplasms; Resveratrol; Stilbenes | 2003 |
Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review).
Topics: Animals; Anticarcinogenic Agents; Cell Line, Tumor; Diet; Humans; In Vitro Techniques; Models, Chemical; Neoplasms; Resveratrol; Stilbenes | 2003 |
From sandwiches to center stage. Peanuts pack a powerful nutritional punch.
Topics: Arachis; Coronary Disease; Fatty Acids, Monounsaturated; Health Promotion; Humans; Menu Planning; Neoplasms; Phytosterols; Resveratrol; Stilbenes; Stroke | 2003 |
Pleiotropic effects of resveratrol.
Topics: Antineoplastic Agents, Phytogenic; Coronary Disease; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Gene Expression; Isoenzymes; Neoplasms; Pain; Prostaglandin-Endoperoxide Synthases; Resveratrol; Stilbenes | 2003 |
Wine and resveratrol: mechanisms of cancer prevention?
Topics: Alcohol Drinking; Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Chemoprevention; Humans; Mortality; Neoplasms; Resveratrol; Risk Factors; Stilbenes; Wine | 2003 |
Relationship between mechanisms, bioavailibility, and preclinical chemopreventive efficacy of resveratrol: a conundrum.
Topics: Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Biological Availability; Humans; Neoplasms; Palliative Care; Phenols; Resveratrol; Ribonucleotide Reductases; Rodentia; Stilbenes; Vasodilator Agents | 2003 |
Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets.
Topics: Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Chemoprevention; Humans; Neoplasms; NF-kappa B; Resveratrol; Signal Transduction; Stilbenes; Transcription Factor AP-1 | 2004 |
Chemotherapeutic potential of the chemopreventive phytoalexin resveratrol.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Biological Availability; Cell Line, Tumor; Humans; Neoplasms; Phytoalexins; Plant Extracts; Resveratrol; Sesquiterpenes; Stilbenes; Terpenes | 2004 |
Nutraceuticals as anti-angiogenic agents: hopes and reality.
Topics: Angiogenesis Inhibitors; Animals; Atherosclerosis; Catechin; Curcumin; Dietary Supplements; Flavonoids; Humans; Neoplasms; Neovascularization, Pathologic; Phenols; Polyphenols; Resveratrol; Stilbenes; Vascular Endothelial Growth Factor A | 2005 |
Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Cell Cycle; Humans; Neoplasms; Radiation-Sensitizing Agents; Resveratrol; Stilbenes | 2006 |
Therapeutic potential of resveratrol: the in vivo evidence.
Topics: Aging; Animals; Heart Diseases; Humans; Inflammation; Myocardial Infarction; Neoplasms; Protective Agents; Resveratrol; Stilbenes; Stroke | 2006 |
[Resveratrol--evaluation of anticancer activity].
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Evaluation Studies as Topic; Humans; Neoplasm Transplantation; Neoplasms; Plant Extracts; Resveratrol; Stilbenes; Wine | 2006 |
The roles of polyphenols in cancer chemoprevention.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Carcinogens; Catechin; Cell Communication; Cyclooxygenase Inhibitors; Diet; Flavonoids; Gap Junctions; Genistein; Humans; Matrix Metalloproteinases; Neoplasms; Oxidative Stress; Phenols; Polyphenols; Prostaglandin-Endoperoxide Synthases; Quercetin; Reactive Oxygen Species; Resveratrol; Signal Transduction; Stilbenes | 2006 |
Resveratrol modulation of signal transduction in apoptosis and cell survival: a mini-review.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Cell Survival; Humans; Inhibitor of Apoptosis Proteins; MAP Kinase Signaling System; Microtubule-Associated Proteins; Mitochondria; Models, Biological; Neoplasm Proteins; Neoplasms; NF-kappa B; Protein-Tyrosine Kinases; Resveratrol; Signal Transduction; Stilbenes; Survivin | 2006 |
The proteasome as a potential target for novel anticancer drugs and chemosensitizers.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Catechin; Clinical Trials as Topic; Curcumin; Drug Resistance, Neoplasm; Drug Therapy, Combination; Genistein; Humans; Neoplasms; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Radiation-Sensitizing Agents; Resveratrol; Stilbenes; Structure-Activity Relationship; Ubiquitin | 2006 |
Resveratrol: a review of preclinical studies for human cancer prevention.
Topics: Animals; Anticarcinogenic Agents; Drug Screening Assays, Antitumor; Humans; Neoplasms; Resveratrol; Stilbenes | 2007 |
Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential.
Topics: Cardiovascular Diseases; Cell Cycle; Chemoprevention; Chemotherapy, Adjuvant; Diabetes Mellitus; Gene Expression Regulation; Humans; Inflammation; Neoplasms; Neovascularization, Pathologic; Resveratrol; Signal Transduction; Stilbenes | 2007 |
Predicting the physiological relevance of in vitro cancer preventive activities of phytochemicals.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Catechin; Curcumin; Humans; Indoles; Neoplasms; Resveratrol; Stilbenes | 2007 |
Cell cycle control as a basis for cancer chemoprevention through dietary agents.
Topics: Animals; Anticarcinogenic Agents; Apigenin; Catechin; Cell Cycle; Cell Proliferation; Curcumin; Cyclin-Dependent Kinases; Diet; Genistein; Humans; Neoplasms; Resveratrol; Silymarin; Stilbenes; Tea | 2008 |
New enlightenment of French Paradox: resveratrol's potential for cancer chemoprevention and anti-cancer therapy.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Cardiovascular Diseases; Cell Line, Tumor; Cell Transformation, Neoplastic; Clinical Trials as Topic; Diet; Europe; France; Gene Expression Regulation, Neoplastic; Humans; Incidence; Mice; Mice, Inbred A; Neoplasms; Resveratrol; Stilbenes; Wine | 2007 |
Cancer chemoprevention through dietary antioxidants: progress and promise.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Carotenoids; Curcumin; Dietary Supplements; Fruit; Genistein; Humans; Lycopene; Neoplasms; Oxidative Stress; Pentacyclic Triterpenes; Resveratrol; Stilbenes; Triterpenes | 2008 |
Resveratrol: a multitargeted agent for age-associated chronic diseases.
Topics: Aging; Cardiotonic Agents; Gene Expression Regulation; Gene Regulatory Networks; Inflammation; Intracellular Signaling Peptides and Proteins; Neoplasms; Platelet Aggregation; Resveratrol; Stilbenes; Transcription Factors | 2008 |
Chemoprevention of cancer and cardiovascular disease by resveratrol.
Topics: Anticarcinogenic Agents; Carcinogens; Cardiovascular Diseases; Cell Cycle; Cyclin D1; Enzyme Inhibitors; Gene Expression Regulation; Growth Substances; Humans; Lipid Peroxidation; Neoplasms; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidative Stress; Phosphorylation; Protein Processing, Post-Translational; Reactive Oxygen Species; Receptor Protein-Tyrosine Kinases; Resveratrol; Risk Factors; Rosales; Signal Transduction; Stilbenes; Transcription, Genetic; Wine | 1999 |
Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances.
Topics: Animals; Capsaicin; Catechin; Catechols; Curcumin; Diet; Fatty Alcohols; Humans; Mice; Neoplasms; Neoplasms, Experimental; Phenols; Plants, Edible; Plants, Medicinal; Resveratrol; Stilbenes | 1999 |
[Biological activity of resveratrol].
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Cardiovascular Diseases; Humans; Inflammation; Neoplasms; Resveratrol; Ribonucleotide Reductases; Stilbenes | 2001 |
Resveratrol--from the bottle to the bedside?
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Fas Ligand Protein; fas Receptor; Humans; Membrane Glycoproteins; Neoplasms; Resveratrol; Stilbenes | 2001 |
A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Cell Transformation, Neoplastic; Humans; Neoplasms; Resveratrol; Stilbenes | 2001 |
The world of resveratrol.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Arteriosclerosis; Biological Availability; Cell Division; Gene Transfer, Horizontal; Humans; Inflammation; Intestinal Absorption; Neoplasms; Resveratrol; Stilbenes; Vitis | 2001 |
The effects of resveratrol on CYP1A1 expression and aryl hydrocarbon receptor function in vitro.
Topics: Anticarcinogenic Agents; Cytochrome P-450 CYP1A1; Humans; Neoplasms; Receptors, Aryl Hydrocarbon; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2001 |
Resveratrol and cancer: a review.
Topics: Antineoplastic Agents, Phytogenic; Estrogens; Humans; Neoplasms; Polygonum; Receptors, Estrogen; Resveratrol; Stilbenes; Xenobiotics | 2002 |
Cancer chemopreventive activity of resveratrol.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Humans; Neoplasms; Resveratrol; Stilbenes | 2002 |
Molecular targets for nutrients involved with cancer prevention.
Topics: Anticarcinogenic Agents; Calcium; Diet; Folic Acid; Food Technology; Genistein; Humans; Neoplasms; Nutritional Physiological Phenomena; Polymorphism, Genetic; Resveratrol; Selenium; Stilbenes; Vitamin D | 2001 |
3 trial(s) available for resveratrol and Neoplasms
| Article | Year |
|---|---|
Topics: 3-Hydroxybutyric Acid; Acetazolamide; Acrylates; Administration, Intravenous; Adolescent; Adult; Aerosols; Afghanistan; Aflatoxin M1; Agaricales; Aged; Aged, 80 and over; Agricultural Irrigation; Air Pollutants; alpha-L-Fucosidase; Amino Acid Sequence; Androgen Antagonists; Animals; Antibodies, Bacterial; Antigens, Bacterial; Antineoplastic Agents; Antioxidants; Apoptosis; Artifacts; Autophagy; B7-H1 Antigen; Bacterial Proteins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Bile; Bioelectric Energy Sources; Biosensing Techniques; Body Mass Index; Brain; Brazil; Breast Neoplasms; Bufo arenarum; Burkholderia; C-Reactive Protein; Cadmium; Carbon Compounds, Inorganic; Carbon-13 Magnetic Resonance Spectroscopy; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Carcinoma, Transitional Cell; Case-Control Studies; CD4-Positive T-Lymphocytes; Cell Count; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Characiformes; Child; China; Cities; Cobalt; Colonic Neoplasms; Copper Sulfate; Cross-Sectional Studies; Cyclin-Dependent Kinase Inhibitor p16; Cytokines; Deoxycytidine; Diagnosis, Differential; Digestive System; Dihydroxyphenylalanine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA Barcoding, Taxonomic; DNA, Bacterial; Dose-Response Relationship, Drug; Down-Regulation; Edetic Acid; Electrochemical Techniques; Electrodes; Embolization, Therapeutic; Embryo, Nonmammalian; Environmental Monitoring; Enzyme-Linked Immunosorbent Assay; Epithelial-Mesenchymal Transition; Fatty Acids; Feces; Female; Follow-Up Studies; Food Contamination; Forkhead Box Protein M1; Fresh Water; Fungicides, Industrial; Gallium Isotopes; Gallium Radioisotopes; Gastrectomy; Gastric Bypass; Gastric Outlet Obstruction; Gastroplasty; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Bacterial; Genetic Markers; Genome, Bacterial; Genome, Mitochondrial; Glioma; Glycogen Synthase Kinase 3 beta; Goats; Gonads; Guatemala; Halomonadaceae; HEK293 Cells; Helicobacter Infections; Helicobacter pylori; Hepacivirus; Histone-Lysine N-Methyltransferase; Hormones; Humans; Hydroxybutyrate Dehydrogenase; Hypersplenism; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Iran; Japan; Lactuca; Laparoscopy; Larva; Ligands; Liver Neoplasms; Lymphocyte Activation; Macrophages; Malaria; Male; Mercury; Metabolic Syndrome; Metals, Heavy; Mice; Middle Aged; Milk, Human; Mitochondria; Models, Molecular; Molecular Structure; Mothers; Multilocus Sequence Typing; Muscles; Mutation; Nanocomposites; Nanotubes, Carbon; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Cells, Circulating; Neoplastic Stem Cells; Neuroimaging; Nitriles; Nitrogen Isotopes; Non-alcoholic Fatty Liver Disease; Nuclear Magnetic Resonance, Biomolecular; Obesity; Obesity, Morbid; Oligopeptides; Oxidation-Reduction; Pancreatic Neoplasms; Particle Size; Particulate Matter; Pepsinogen A; Pesticides; Pharmacogenetics; Phosphatidylinositol 3-Kinases; Phospholipids; Phylogeny; Plasmodium ovale; Plasmodium vivax; Platelet Count; Polyhydroxyalkanoates; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postoperative Complications; Pregnancy; Prevalence; Prognosis; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Domains; Proto-Oncogene Proteins c-akt; Proton Magnetic Resonance Spectroscopy; Pseudogenes; PTEN Phosphohydrolase; Pyrazoles; Pyrimidines; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Rats, Long-Evans; Rats, Sprague-Dawley; RAW 264.7 Cells; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptor, Notch3; Receptors, G-Protein-Coupled; Receptors, Urokinase Plasminogen Activator; Recombinant Proteins; Repressor Proteins; Resveratrol; Retrospective Studies; Risk Assessment; Risk Factors; RNA, Messenger; RNA, Ribosomal, 16S; Salinity; Salvage Therapy; Seasons; Sequence Analysis, DNA; Seroepidemiologic Studies; Signal Transduction; Skin; Snails; Soluble Guanylyl Cyclase; Solutions; Spain; Species Specificity; Spheroids, Cellular; Splenic Artery; Stomach Neoplasms; Streptococcus pneumoniae; Structure-Activity Relationship; Sulfonamides; Sunlight; Surface Properties; Surgical Instruments; Surgical Wound Infection; Survival Rate; Tetrahydrouridine; Thinness; Thrombocytopenia; Tissue Distribution; Titanium; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Tumor Microenvironment; Tumor Necrosis Factor-alpha; Turkey; Ubiquinone; Urologic Neoplasms; Viral Envelope Proteins; Wastewater; Water Pollutants, Chemical; Weather; Wnt Signaling Pathway; Xenograft Model Antitumor Assays; Young Adult | 2007 |
Resveratrol levels and all-cause mortality in older community-dwelling adults.
Topics: Aged; Cardiovascular Diseases; Cohort Studies; Female; Humans; Incidence; Inflammation; Italy; Male; Mortality; Neoplasms; Prevalence; Prospective Studies; Resveratrol; Stilbenes | 2014 |
Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent.
Topics: Adult; Anticarcinogenic Agents; Area Under Curve; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Neoplasms; Resveratrol; Stilbenes; Tandem Mass Spectrometry | 2007 |
115 other study(ies) available for resveratrol and Neoplasms
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Synthesis, structural characterisation and biological evaluation of fluorinated analogues of resveratrol.
Topics: Antibiotics, Antineoplastic; Anticarcinogenic Agents; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Epirubicin; Halogenation; Humans; Molecular Structure; Neoplasms; Resveratrol; Stilbenes; Structure-Activity Relationship | 2009 |
The lipogenesis pathway as a cancer target.
Topics: Acetyl-CoA Carboxylase; Animals; Antineoplastic Agents; ATP Citrate (pro-S)-Lyase; Biosynthetic Pathways; Fatty Acid Synthases; Fatty Acids; Humans; Lipogenesis; Models, Chemical; Molecular Structure; Neoplasms | 2011 |
Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets.
Topics: Antineoplastic Agents; Aromatase; Binding Sites; Catalytic Domain; Chemoprevention; Computer Simulation; Enzyme Activation; Humans; NAD(P)H Dehydrogenase (Quinone); Neoplasms; NF-kappa B; Resveratrol; Stilbenes; Structure-Activity Relationship; Thiadiazoles | 2012 |
Design, synthesis, and biological evaluation of benzoselenazole-stilbene hybrids as multi-target-directed anti-cancer agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Drug Design; Flow Cytometry; Humans; Neoplasms; Organoselenium Compounds; Stilbenes; Thioredoxin Reductase 1; Tumor Cells, Cultured | 2015 |
1,4-Dihydropyridines Active on the SIRT1/AMPK Pathway Ameliorate Skin Repair and Mitochondrial Function and Exhibit Inhibition of Proliferation in Cancer Cells.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Proliferation; Dihydropyridines; Enzyme Activation; Humans; Male; Mice; Mitochondria; Neoplasms; Signal Transduction; Sirtuin 1; Skin; Wound Healing | 2016 |
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Biological Availability; Drug Delivery Systems; Humans; Neoplasms; Phytochemicals; Polyphenols | 2017 |
Cancer Stem Cell (CSC) Inhibitors in Oncology-A Promise for a Better Therapeutic Outcome: State of the Art and Future Perspectives.
Topics: Antineoplastic Agents; Autophagy; Benzofurans; Cell Cycle Proteins; Dasatinib; Drug Repositioning; Epigenomics; Humans; Nanotechnology; Naphthoquinones; Neoplasms; Neoplastic Stem Cells; Protein Kinase Inhibitors; Resveratrol; Signal Transduction; Terpenes | 2020 |
The use of resveratrol in the treatment of obstructive sleep apnea and cancer: a commentary on common targets.
Topics: Humans; Neoplasms; Polysomnography; Resveratrol; Sleep Apnea, Obstructive | 2022 |
Modulation of lncRNA H19 enhances resveratrol-inhibited cancer cell proliferation and migration by regulating endoplasmic reticulum stress.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Endoplasmic Reticulum Stress; Humans; Neoplasms; Resveratrol; RNA, Long Noncoding | 2022 |
Involvement of microRNA modifications in anticancer effects of major polyphenols from green tea, coffee, wine, and curry.
Topics: Animals; Catechin; Coffee; Curcumin; MicroRNAs; Neoplasms; Polyphenols; Reactive Oxygen Species; Resveratrol; Tea; Wine | 2023 |
Resveratrol in Cancer Treatment with a Focus on Breast Cancer.
Topics: Animals; Apoptosis; Cell Proliferation; Female; Neoplasms; Resveratrol; Signal Transduction | 2023 |
Bioactivity of hamamelitannin, flavokawain A, and triacetyl resveratrol as natural compounds: Molecular docking study, anticolon cancer, and anti-Alzheimer potentials.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; Molecular Docking Simulation; Molecular Structure; Neoplasms; Resveratrol; Structure-Activity Relationship | 2023 |
Resveratrol Carbon Dots Disrupt Mitochondrial Function in Cancer Cells.
Topics: Antineoplastic Agents; Apoptosis; Calcium; Carbon; Curcumin; Electron Transport Complex IV; Mitochondria; Neoplasms; Polyphenols; Resveratrol; Stilbenes | 2022 |
Olaparib enhances the Resveratrol-mediated apoptosis in breast cancer cells by inhibiting the homologous recombination repair pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; DNA; Endonucleases; Humans; Mice; Neoplasms; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Recombinational DNA Repair; Resveratrol | 2022 |
Resveratrol reverses TGF-β1-mediated invasion and metastasis of breast cancer cells via the SIRT3/AMPK/autophagy signal axis.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Humans; Mice; Neoplasms; Resveratrol; Sirtuin 3; Transforming Growth Factor beta1 | 2023 |
Resveratrol reduces lactate production and modifies the ovarian cancer immune microenvironment.
Topics: Carcinoma, Ovarian Epithelial; Female; Humans; Immune Checkpoint Inhibitors; Lactic Acid; Neoplasms; Ovarian Neoplasms; Polyphenols; Programmed Cell Death 1 Receptor; Resveratrol; Tumor Microenvironment | 2022 |
Synthesis and Inhibitory Activity of Machaeridiol-Based Novel Anti-MRSA and Anti-VRE Compounds and Their Profiling for Cancer-Related Signaling Pathways.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biological Products; Luciferases; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Monoterpenes; Neoplasms; Resveratrol; Signal Transduction; Transcription Factors; Vancomycin | 2022 |
Trans-gnetin H isolated from the seeds of Paeonia species induces autophagy via inhibiting mTORC1 signalling through AMPK activation.
Topics: AMP-Activated Protein Kinases; Autophagy; Humans; Mechanistic Target of Rapamycin Complex 1; Neoplasms; Paeonia; Resveratrol; Seeds; Stilbenes | 2023 |
Exploring binding mode assessment of novel kaempferol, resveratrol, and quercetin derivatives with PPAR-α as potent drug candidates against cancer.
Topics: Kaempferols; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Neoplasms; PPAR alpha; Quercetin; Resveratrol | 2023 |
Design, development and evaluation of Resveratrol transdermal patches for breast cancer therapy.
Topics: Administration, Cutaneous; Animals; Female; Neoplasms; Povidone; Rats; Resveratrol; Skin; Skin Absorption; Transdermal Patch | 2023 |
Resveratrol induces DNA damage-mediated cancer cell senescence through the DLC1-DYRK1A-EGFR axis.
Topics: Animals; Cell Line, Tumor; Cellular Senescence; Chick Embryo; DNA Damage; ErbB Receptors; GTPase-Activating Proteins; Humans; Neoplasms; Resveratrol; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2023 |
Application of self-organizing maps to AFM-based viscoelastic characterization of breast cancer cell mechanics.
Topics: Algorithms; Microscopy, Atomic Force; Neoplasms; Neural Networks, Computer; Resveratrol; Viscosity | 2023 |
Design of Sonosensitizers Integrated with Resveratrol Motif for Synergetic Sonodynamic Therapy and Nuclear Factor Kappa B Transcription Suppression of Breast Cancer.
Topics: Animals; Breast Neoplasms; Female; Humans; MCF-7 Cells; Mice; Neoplasms; NF-kappa B; Resveratrol; Ultrasonic Therapy | 2023 |
Histochemical, Immunohistochemical, and Biochemical Investigation of the Effect of Resveratrol on Testicular Damage Caused by Methotrexate (MTX).
Topics: Animals; Antioxidants; Biomarkers; Male; Methotrexate; Neoplasms; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Serum Albumin; Sulfhydryl Compounds | 2023 |
Codelivery of resveratrol melatonin utilizing pH responsive sericin based nanocarriers inhibits the proliferation of breast cancer cell line at the different pH.
Topics: Antineoplastic Agents; Cell Proliferation; Drug Carriers; Drug Delivery Systems; Humans; Hydrogen-Ion Concentration; MCF-7 Cells; Melatonin; Nanoparticles; Neoplasms; Resveratrol; Sericins; Spectroscopy, Fourier Transform Infrared | 2023 |
Targeted cancer treatment using a combination of siRNA-liposomes and resveratrol-electrospun fibers in co-cultures.
Topics: Cell Survival; Cells, Cultured; Coculture Techniques; Drug Delivery Systems; Fusion Proteins, bcr-abl; Gelatin; Gene Silencing; Human Umbilical Vein Endothelial Cells; Humans; K562 Cells; Liposomes; Neoplasms; Polyesters; Resveratrol; RNA, Small Interfering | 2019 |
Bi-faceted delivery of phytochemicals through chitosan nanoparticles impregnated nanofibers for cancer therapeutics.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Chitosan; Coumaric Acids; Drug Delivery Systems; Drug Liberation; Humans; Nanofibers; Nanoparticles; Neoplasms; Phytochemicals; Polyesters; Reactive Oxygen Species; Resveratrol | 2020 |
Role of Resveratrol in Modulating microRNAs in Human Diseases: From Cancer to Inflammatory Disorder.
Topics: Anti-Inflammatory Agents; Antioxidants; Humans; MicroRNAs; Neoplasms; Resveratrol; Stilbenes | 2021 |
Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity.
Topics: Antineoplastic Agents; B7-H1 Antigen; Carrier Proteins; Glycosylation; Humans; Immunomodulation; Models, Biological; Models, Molecular; Neoplasms; Protein Binding; Protein Multimerization; Resveratrol; Signal Transduction; Structure-Activity Relationship; T-Lymphocytes | 2020 |
Finding a resveratrol analogue as potential anticancer agent with apoptosis and cycle arrest.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Cell Cycle Checkpoints; Cell Proliferation; HeLa Cells; Humans; MCF-7 Cells; Neoplasms; Organic Chemistry Phenomena; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Structure-Activity Relationship | 2020 |
SIRT1-NOX4 signaling axis regulates cancer cachexia.
Topics: Adipose Tissue; Animals; Cachexia; Cell Line; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Forkhead Transcription Factors; HEK293 Cells; Humans; Metabolome; Mice; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Atrophy; NADPH Oxidase 4; Neoplasms; NF-kappa B; Oxidation-Reduction; Pancreatic Neoplasms; Protein Stability; Reactive Oxygen Species; Resveratrol; Signal Transduction; Sirtuin 1; Wasting Syndrome | 2020 |
The Interplay Between Antioxidants and the Immune System: A Promising Field, Still Looking for Answers.
Topics: Antioxidants; Autoimmune Diseases; Cardiovascular Diseases; Humans; Immune System; Metabolic Diseases; Neoplasms; Resveratrol | 2020 |
Resveratrol Inhibition of Renal Cancer Stem Cell Characteristics and Modulation of the Sonic Hedgehog Pathway.
Topics: Cell Proliferation; Cells, Cultured; Hedgehog Proteins; Humans; Neoplasms; Neoplastic Stem Cells; Resveratrol; Signal Transduction | 2021 |
Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach to reveal potent PPAR- γ agonist against cancer.
Topics: Kaempferols; Molecular Docking Simulation; Molecular Dynamics Simulation; Neoplasms; PPAR gamma; Quercetin; Resveratrol | 2022 |
Study of the controversial resveratrol that interact with the endogenous glutathione thiyl radical in cancer cells.
Topics: Free Radicals; Glutathione; Humans; Neoplasms; Resveratrol | 2020 |
Combination of dihydroartemisinin and resveratrol effectively inhibits cancer cell migration
Topics: Antineoplastic Agents; Artemisinins; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Drug Synergism; Drug Therapy, Combination; GTPase-Activating Proteins; Humans; Neoplasms; Resveratrol; Tumor Protein, Translationally-Controlled 1; Tumor Suppressor Proteins | 2020 |
Enhanced response to PD-L1 silencing by modulation of TME via balancing glucose metabolism and robust co-delivery of siRNA/Resveratrol with dual-responsive polyplexes.
Topics: Animals; B7-H1 Antigen; Cell Line, Tumor; Glucose; Mice; Neoplasms; Resveratrol; RNA, Small Interfering; Tumor Microenvironment | 2021 |
Colorectal Adenocarcinoma Cell Culture in a Microfluidically Controlled Environment with a Static Molecular Gradient of Polyphenol.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Curcumin; Drug Screening Assays, Antitumor; Flavanones; Humans; Lab-On-A-Chip Devices; Microfluidic Analytical Techniques; Microfluidics; Neoplasms; Polyphenols; Resveratrol; Tumor Microenvironment | 2021 |
Development and preclinical evaluation of microneedle-assisted resveratrol loaded nanostructured lipid carriers for localized delivery to breast cancer therapy.
Topics: Animals; Drug Carriers; Drug Delivery Systems; Lipids; Nanostructures; Neoplasms; Particle Size; Rats; Resveratrol | 2021 |
Resveratrol: A Vital Therapeutic Agent with Multiple Health Benefits.
Topics: Antioxidants; Humans; Neoplasms; Resveratrol; Stilbenes | 2022 |
Curcumin and Resveratrol Improve Muscle Function and Structure through Attenuation of Proteolytic Markers in Experimental Cancer-Induced Cachexia.
Topics: Animals; Biomarkers; Cachexia; Cell Line; Curcumin; Female; Mice, Inbred BALB C; Muscle Proteins; Muscles; Muscular Atrophy; Neoplasms; Phenotype; Proteolysis; Resveratrol; Signal Transduction; Sirtuin 1 | 2021 |
Janus-faced Acrolein prevents allergy but accelerates tumor growth by promoting immunoregulatory Foxp3+ cells: Mouse model for passive respiratory exposure.
Topics: Acrolein; Allergens; Animals; Antibody Formation; Cytokines; Disease Models, Animal; Forkhead Transcription Factors; Hypersensitivity; Immunologic Factors; Lung; Mice; Neoplasms; NF-kappa B; Receptors, Aryl Hydrocarbon; Resveratrol; Signal Transduction; Stilbenes; T-Lymphocytes, Regulatory | 2017 |
Antitumor activity of resveratrol is independent of Cu(II) complex formation in MCF-7 cell line.
Topics: Antineoplastic Agents; Apoptosis; Coordination Complexes; Copper; Humans; MCF-7 Cells; Neoplasms; Oxidative Stress; Reactive Oxygen Species; Resveratrol; Stilbenes | 2017 |
Nicotine Exposure Augments Renal Toxicity of 5-aza-cytidine Through p66shc: Prevention by Resveratrol.
Topics: Antioxidants; Azacitidine; Cell Line; Heme Oxygenase-1; Humans; Kidney Tubules, Proximal; Neoplasms; NF-E2-Related Factor 2; Nicotine; Oxidative Stress; Promoter Regions, Genetic; Resveratrol; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 1; Stilbenes | 2017 |
Effects of berberine, curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells-Power of nutraceuticals.
Topics: Animals; Antineoplastic Agents; Berberine; Cardiovascular Diseases; Curcumin; Dietary Supplements; Humans; Neoplasms; Resveratrol; Signal Transduction | 2018 |
Dietary Compound Resveratrol Is a Pan-BET Bromodomain Inhibitor.
Topics: Acetylation; Antineoplastic Agents, Phytogenic; Cell Cycle Proteins; Diet; Epigenesis, Genetic; Gene Expression; Histones; Humans; Kinetics; Lysine; Molecular Docking Simulation; Neoplasms; Nuclear Proteins; Phytotherapy; Plant Extracts; Proteins; Resveratrol; Stilbenes; Transcription Factors | 2017 |
The inhibition of indoleamine 2, 3-dioxygenase 1 by connexin 43.
Topics: Animals; Cell Line, Tumor; Connexin 43; Gene Knockdown Techniques; Humans; Immune Tolerance; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Neoplasms; Resveratrol; RNA Interference; RNA, Small Interfering; Salmonella enterica; Signal Transduction; Stilbenes; T-Lymphocytes; Up-Regulation | 2017 |
Resveratrol induces autophagy-dependent apoptosis in HL-60 cells.
Topics: Adenine; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Gene Knockdown Techniques; HL-60 Cells; Humans; Neoplasms; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Resveratrol; RNA, Small Interfering; Signal Transduction; TOR Serine-Threonine Kinases | 2018 |
Novel Resveratrol-chalcone Derivatives: Synthesis and Biological Evaluation.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chalcones; Humans; Inflammation; Mice; Neoplasms; RAW 264.7 Cells; Resveratrol | 2019 |
Resveratrol inhibits Erk1/2-mediated adhesion of cancer cells via activating PP2A-PTEN signaling network.
Topics: Butadienes; Cell Adhesion; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; HeLa Cells; HT29 Cells; Humans; Insulin-Like Growth Factor I; MAP Kinase Kinase 1; MAP Kinase Signaling System; Neoplasms; Nitriles; Okadaic Acid; Oncogene Protein v-akt; Protein Phosphatase 2; PTEN Phosphohydrolase; Resveratrol; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |
Topical Plant Polyphenols Prevent Type I Interferon Signaling in the Skin and Suppress Contact Hypersensitivity.
Topics: Administration, Topical; Animals; Cells, Cultured; Cetuximab; Chemokine CXCL10; Dermatitis, Allergic Contact; Disease Models, Animal; Gefitinib; Humans; Interferon Regulatory Factor-1; Interferon Type I; Keratinocytes; Mice; Neoplasms; Phosphorylation; Plant Extracts; Polyphenols; Quercetin; Resveratrol; Signal Transduction; STAT1 Transcription Factor | 2018 |
Resveratrol derivatives from Commiphora africana (A. Rich.) Endl. display cytotoxicity and selectivity against several human cancer cell lines.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Biological Products; Cell Line, Tumor; Commiphora; Humans; Neoplasms; Plants, Medicinal; Resveratrol | 2019 |
Synthesis and biological evaluation of quercetin and resveratrol peptidyl derivatives as potential anticancer and antioxidant agents.
Topics: Antineoplastic Agents; Antioxidants; Cell Proliferation; Chromatography, High Pressure Liquid; Dietary Supplements; Enkephalin, Leucine; Enkephalin, Methionine; Esters; HCT116 Cells; Humans; MCF-7 Cells; Neoplasms; Peptides; Phytochemicals; Quercetin; Resveratrol; Solubility; Transforming Growth Factor beta | 2019 |
Resveratrol inhibits the growth of tumor cells under chronic stress via the ADRB‑2‑HIF‑1α axis.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Neoplasms; Receptors, Adrenergic, beta-2; Resveratrol; Signal Transduction | 2019 |
Resveratrol-Responsive CArG Elements from the Egr-1 Promoter for the Induction of GADD45α to Arrest the G2/M Transition.
Topics: A549 Cells; Adenocarcinoma; Cell Cycle Checkpoints; Cell Cycle Proteins; Early Growth Response Protein 1; Genes, Transgenic, Suicide; Genetic Therapy; Humans; Lung Neoplasms; Neoplasms; Nuclear Proteins; Response Elements; Resveratrol; Transcriptional Activation | 2019 |
Deciphering the metabolic secret of longevity through the analysis of metabolic response to stress on long-lived species.
Topics: Aging; Animals; Homeostasis; Humans; Longevity; Metabolomics; Mice; Models, Theoretical; Mole Rats; NAD; Neoplasms; Oxidative Stress; Rats; Resveratrol; Species Specificity; Spermidine; Stress, Physiological | 2019 |
One-step synthesis of phyto-polymer coated gold nanospheres as a delivery system to enhance resveratrol cytotoxicity.
Topics: Antineoplastic Agents, Phytogenic; Chlorides; Drug Carriers; Drug Compounding; Drug Screening Assays, Antitumor; Gold Compounds; Hep G2 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Metal Nanoparticles; Nanospheres; Neoplasms; Resveratrol | 2019 |
Resveratrol inhibits cancer cell proliferation by impairing oxidative phosphorylation and inducing oxidative stress.
Topics: 3T3 Cells; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; MCF-7 Cells; Mice; Mitophagy; Neoplasm Metastasis; Neoplasms; Oxidative Phosphorylation; Oxidative Stress; Phytochemicals; Resveratrol | 2019 |
Evidence of the effectiveness of Resveratrol in the prevention of guanine one-electron oxidation: possible benefits in cancer prevention.
Topics: Antioxidants; Electrons; Guanine; Neoplasms; Oxidation-Reduction; Resveratrol | 2019 |
Can resveratrol in wine protect against the carcinogenicity of ethanol? A probabilistic dose-response assessment.
Topics: Animals; Antioxidants; Carcinogens; Ethanol; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Monte Carlo Method; Neoplasms; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Wine | 2014 |
Antitumor effects of naturally occurring oligomeric resveratrol derivatives.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Survival; Dose-Response Relationship, Drug; Genes, p16; HeLa Cells; Humans; MCF-7 Cells; Mice; Mice, Nude; Neoplasms; p38 Mitogen-Activated Protein Kinases; Polymers; Resveratrol; Stilbenes; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2013 |
Experimental and computational studies on newly synthesized resveratrol derivative: a new method for cancer chemoprevention and therapeutics?
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Binding Sites; Cell Line, Tumor; DNA; DNA Fragmentation; Fas Ligand Protein; Gene Expression Regulation, Neoplastic; Humans; Interleukin-8; Molecular Docking Simulation; Neoplasms; NF-kappa B; Poly(ADP-ribose) Polymerases; Protein Binding; Receptors, Tumor Necrosis Factor; Resveratrol; Stereoisomerism; Stilbenes; Tumor Necrosis Factor-alpha | 2013 |
Interferon gamma induced by resveratrol analog, HS-1793, reverses the properties of tumor associated macrophages.
Topics: Animals; Cell Line, Tumor; Cell Movement; Female; Interferon-gamma; Macrophages; Mice; Mice, Inbred C3H; Naphthols; Neoplasm Invasiveness; Neoplasms; Resorcinols; Resveratrol; Stilbenes | 2014 |
Immunomodulatory effects of high-protein diet with resveratrol supplementation on radiation-induced acute-phase inflammation in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Deoxyguanosine; Diet; Dietary Proteins; Dietary Supplements; Female; Immune System; Inflammation; Leukocyte Count; Lipid Metabolism; Lipids; Neoplasms; Phytotherapy; Plant Extracts; Platelet Count; Radiation Injuries, Experimental; Rats, Wistar; Resveratrol; Stilbenes | 2014 |
Production of anti-cancer agent using microbial biotransformation.
Topics: Antineoplastic Agents; Biotransformation; Fermentation; Gas Chromatography-Mass Spectrometry; HeLa Cells; Humans; Hydroxylation; Neoplasms; Resveratrol; Stilbenes; Streptomyces | 2014 |
Resveratrol enhances palmitate-induced ER stress and apoptosis in cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; DNA-Binding Proteins; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Hep G2 Cells; Humans; Neoplasms; Palmitates; Reactive Oxygen Species; Regulatory Factor X Transcription Factors; Resveratrol; Stearoyl-CoA Desaturase; Stilbenes; Transcription Factor CHOP; Transcription Factors; Triglycerides; X-Box Binding Protein 1 | 2014 |
Resveratrol-loaded polymeric nanoparticles suppress glucose metabolism and tumor growth in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Survival; Drug Liberation; Glucose; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Poly(ADP-ribose) Polymerases; Polyethylene Glycols; Reactive Oxygen Species; Resveratrol; Stilbenes; Tumor Burden | 2015 |
3,4',5-trans-Trimethoxystilbene; a natural analogue of resveratrol with enhanced anticancer potency.
Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Line, Tumor; Cell Proliferation; Free Radical Scavengers; Humans; Inhibitory Concentration 50; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Resveratrol; Stilbenes; Xenograft Model Antitumor Assays | 2015 |
Nanopotentiated combination cancer therapy: Chemotherapeutic and chemosensitizer (2C approach).
Topics: Antineoplastic Agents, Phytogenic; Curcumin; Drug Delivery Systems; Drug Therapy, Combination; Flavonoids; Fluorouracil; Humans; Models, Biological; Nanoparticles; Neoplasms; Resveratrol; Stilbenes | 2015 |
Resveratrol: beneficial or not? Opposite effects of resveratrol on hypoxia-dependent PAI-1 expression in tumour and primary cells.
Topics: Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Hepatocytes; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Neoplasms; Oxygen; Plasminogen Activator Inhibitor 1; Polyphenols; Resveratrol; RNA, Messenger; Stilbenes | 2016 |
Acidosis and Formaldehyde Secretion as a Possible Pathway of Cancer Pain and Options for Improved Cancer Pain Control.
Topics: Acidosis; Aldehyde Dehydrogenase; Dichloroacetic Acid; Formaldehyde; Glutathione; Humans; Hydrogen-Ion Concentration; Lactic Acid; Neoplasms; Pain; Pain Management; Quality of Life; Resveratrol; Sodium Bicarbonate; Stilbenes | 2015 |
Evidence supporting the conceptual framework of cancer chemoprevention in canines.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Chemoprevention; Curcumin; DNA Damage; Dog Diseases; Dogs; Ellagic Acid; Food, Formulated; Genistein; Hydrogen Peroxide; Neoplasms; Oxidative Stress; Quercetin; Resveratrol; Stilbenes; Treatment Outcome | 2016 |
Novel multifunctional pH-sensitive nanoparticles loaded into microbubbles as drug delivery vehicles for enhanced tumor targeting.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Models, Animal; Drug Carriers; Hydrogen-Ion Concentration; Mice; Microbubbles; Molecular Targeted Therapy; Nanoparticles; Neoplasm Transplantation; Neoplasms; Resveratrol; Stilbenes; Treatment Outcome | 2016 |
The resveratrol analogue trimethoxystilbene inhibits cancer cell growth by inducing multipolar cell mitosis.
Topics: Animals; Cell Cycle; Cell Proliferation; Cell Survival; CHO Cells; Cricetulus; HeLa Cells; Humans; Mitosis; Neoplasms; Resveratrol; Stilbenes; Tubulin | 2017 |
A Novel Resveratrol Based Tubulin Inhibitor Induces Mitotic Arrest and Activates Apoptosis in Cancer Cells.
Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Benzene Derivatives; Cell Line, Tumor; Cells, Cultured; G2 Phase Cell Cycle Checkpoints; HEK293 Cells; HeLa Cells; Humans; Mice; Mice, Inbred BALB C; Mitosis; Neoplasms; Neoplasms, Experimental; Polymerization; Resveratrol; Stilbenes; Tubulin; Tubulin Modulators | 2016 |
Resveratrol Induces Cancer Cell Apoptosis through MiR-326/PKM2-Mediated ER Stress and Mitochondrial Fission.
Topics: Apoptosis; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Endoplasmic Reticulum Stress; Gene Expression Regulation, Neoplastic; Humans; Membrane Proteins; MicroRNAs; Mitochondria; Mitochondrial Dynamics; Neoplasms; Resveratrol; Stilbenes; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2016 |
Different effect of resveratrol to induction of apoptosis depending on the type of human cancer cells.
Topics: A549 Cells; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Fragmentation; Enzyme Activation; HCT116 Cells; Hep G2 Cells; Humans; MCF-7 Cells; Mitochondria; Neoplasms; Proto-Oncogene Proteins c-akt; Resveratrol; Sirtuin 1; Stilbenes | 2017 |
Resveratrol sequentially induces replication and oxidative stresses to drive p53-CXCR2 mediated cellular senescence in cancer cells.
Topics: A549 Cells; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cellular Senescence; DNA Replication; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Oxidative Stress; Reactive Oxygen Species; Receptors, Interleukin-8B; Resveratrol; S Phase Cell Cycle Checkpoints; Stilbenes; Tumor Suppressor Protein p53 | 2017 |
Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice.
Topics: Animals; Anticarcinogenic Agents; Cell Cycle; Cell Transformation, Neoplastic; Cells, Cultured; Chromosomal Instability; DNA Damage; DNA Repair; Down-Regulation; Embryo, Mammalian; Female; Gene Expression Regulation, Developmental; Gene Expression Regulation, Neoplastic; Genomic Instability; Gestational Age; Heterochromatin; Histones; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitosis; Mutation; Neoplasms; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes; Time Factors; Tumor Suppressor Proteins | 2008 |
Non-canonical autophagy: an exception or an underestimated form of autophagy?
Topics: Antineoplastic Agents, Phytogenic; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cell Line, Tumor; Humans; Membrane Proteins; Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Stilbenes | 2008 |
Resveratrol and cancer prevention.
Topics: Anticarcinogenic Agents; Humans; Neoplasms; Resveratrol; Stilbenes | 2009 |
Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells.
Topics: Apoptosis Regulatory Proteins; Autophagy; Base Sequence; Beclin-1; Cell Line, Tumor; Consensus Sequence; Gene Expression Regulation, Neoplastic; Humans; Membrane Proteins; MicroRNAs; Molecular Sequence Data; Neoplasms; Oligonucleotide Array Sequence Analysis; Resveratrol; Sirolimus; Stilbenes; Vacuoles | 2009 |
Identification and bioactivities of resveratrol oligomers and flavonoids from Carex folliculata seeds.
Topics: Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Carex Plant; Cell Line, Tumor; Cell Proliferation; Flavonoids; Humans; Methicillin-Resistant Staphylococcus aureus; Neoplasms; Plant Extracts; Resveratrol; Seeds; Stilbenes | 2009 |
Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation.
Topics: AMP-Activated Protein Kinases; Animals; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Female; Gene Expression; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Protein Biosynthesis; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes | 2010 |
Bcl-2 modulates resveratrol-induced ROS production by regulating mitochondrial respiration in tumor cells.
Topics: Apoptosis; Cell Line, Tumor; Humans; Mitochondria; Neoplasms; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Resveratrol; RNA, Small Interfering; Stilbenes | 2010 |
Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer.
Topics: Anticarcinogenic Agents; Aromatase; Aromatase Inhibitors; Chemoprevention; Crystallography, X-Ray; Humans; Models, Molecular; Neoplasms; Quinone Reductases; Resveratrol; Stilbenes; Veratrum | 2010 |
Growth-stimulatory effect of resveratrol in human cancer cells.
Topics: Animals; Female; Humans; Mice; Mice, Nude; Neoplasms; Nervous System Neoplasms; NF-kappa B; Nitriles; Phenols; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes; Sulfones | 2010 |
Nutraceutical inhibition of muscle proteolysis: a role of diallyl sulphide in the treatment of muscle wasting.
Topics: Allyl Compounds; Animals; Anorexia; Cachexia; Catechin; Cells, Cultured; Dietary Supplements; Genistein; Male; Muscle, Skeletal; Muscular Atrophy; Neoplasms; Rats; Rats, Wistar; Resveratrol; Stilbenes; Sulfides; Weight Loss | 2011 |
[Research on the virtues of resveratrol].
Topics: Antioxidants; Humans; Neoplasms; Resveratrol; Stilbenes; Wine | 2010 |
Resveratrol interacts with estrogen receptor-β to inhibit cell replicative growth and enhance stress resistance by upregulating mitochondrial superoxide dismutase.
Topics: Animals; Antioxidants; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Fulvestrant; Gene Expression; Humans; Hydrogen Peroxide; Mice; Mitochondria; Neoplasms; Nitriles; Phenols; Propionates; Pyrazoles; Resveratrol; Stilbenes; Stress, Physiological; Superoxide Dismutase; Up-Regulation | 2011 |
Quantum-chemical study of interactions of trans-resveratrol with guanine-thymine dinucleotide and DNA-nucleobases.
Topics: Adenine; Antineoplastic Agents, Phytogenic; Cytosine; DNA; DNA Breaks; Guanine; Humans; Hydrogen Bonding; Models, Molecular; Neoplasms; Nucleic Acid Conformation; Quantum Theory; Resveratrol; Static Electricity; Stilbenes; Thermodynamics; Thymine; Vacuum; Water | 2011 |
Food: The omnivore's labyrinth.
Topics: Animals; Brassica; Breeding; Cooking; Curcumin; Diet; Fruit; Genetic Variation; Genistein; Genome, Human; Humans; Isothiocyanates; Metagenome; Mice; Neoplasms; Phytotherapy; Rats; Reproducibility of Results; Resveratrol; Risk Management; Stilbenes; Sulfoxides; Thiocyanates; Time Factors; Vegetables | 2011 |
Anti-tumor and immunomodulatory activity of resveratrol in vitro and its potential for combining with cancer immunotherapy.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; Immunotherapy; Leukocytes, Mononuclear; Mice; Mice, Nude; Neoplasms; Resveratrol; Spleen; Stilbenes | 2011 |
Resveratrol dimers are novel sphingosine kinase 1 inhibitors and affect sphingosine kinase 1 expression and cancer cell growth and survival.
Topics: Antineoplastic Agents; Cell Line, Tumor; Enzyme Inhibitors; Humans; Neoplasms; Phosphotransferases (Alcohol Group Acceptor); Resveratrol; Stilbenes | 2012 |
In this issue of the International Reviews of Immunology.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Hepatitis C; Humans; Hypersensitivity; Immune System; Models, Immunological; Myeloid Cells; Neoplasms; Resveratrol; Stilbenes; Viral Hepatitis Vaccines | 2012 |
Pterostilbene-induced tumor cytotoxicity: a lysosomal membrane permeabilization-dependent mechanism.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Caspases; Cell Death; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Flow Cytometry; HSP70 Heat-Shock Proteins; Humans; Inhibitory Concentration 50; L-Lactate Dehydrogenase; Lysosomes; Microscopy, Confocal; Necrosis; Neoplasms; Permeability; Phagosomes; Resveratrol; Stilbenes | 2012 |
Interventions: Live long and prosper.
Topics: Age of Onset; Aging; Animal Diseases; Animals; Biomedical Research; Caloric Restriction; Cardiovascular Diseases; Female; Gene Expression Profiling; Geriatrics; Humans; Longevity; Macaca mulatta; Male; Mice; Models, Animal; Neoplasms; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Resveratrol; Sirolimus; Sirtuins; Somatomedins; Stilbenes; TOR Serine-Threonine Kinases | 2012 |
Resveratrol suppresses tumor progression via the regulation of indoleamine 2,3-dioxygenase.
Topics: Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Dendritic Cells; Indoleamine-Pyrrole 2,3,-Dioxygenase; Janus Kinases; Male; Mice; Mice, Inbred C57BL; Neoplasms; Proto-Oncogene Proteins c-akt; Resveratrol; STAT1 Transcription Factor; Stilbenes; Tumor Escape | 2013 |
Molecular analysis on the chemopreventive properties of resveratrol, a plant polyphenol microcomponent.
Topics: Antineoplastic Agents, Phytogenic; Cell Division; Colonic Neoplasms; Flow Cytometry; Genistein; Hepatoblastoma; Humans; In Vitro Techniques; Neoplasms; Resveratrol; S Phase; Stilbenes; Tumor Cells, Cultured | 2002 |
Inhibition of COX isoforms by nutraceuticals.
Topics: Biflavonoids; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Inflammation; Isoenzymes; Isoflavones; Membrane Proteins; Neoplasms; Plant Extracts; Prostaglandin-Endoperoxide Synthases; Resveratrol; Ruscus; Stilbenes | 2004 |
Resveratrol: a whiff that induces a biologically specific tsunami.
Topics: Angiogenesis Inhibitors; Antioxidants; Chemoprevention; Clinical Trials as Topic; Humans; Neoplasms; Phenols; Resveratrol; Ribonucleotide Reductases; Stilbenes; Vasodilator Agents | 2004 |
Resveratrol may be a powerful cancer-fighting ally.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Cell Line, Tumor; Histone Deacetylases; Humans; Neoplasms; NF-kappa B p50 Subunit; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes; Transcription Factors; Tumor Necrosis Factor-alpha | 2004 |
Resveratrol inhibits cell cycle progression in U937 cells.
Topics: Anticarcinogenic Agents; CDC2-CDC28 Kinases; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Cyclin A; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Growth Inhibitors; Humans; Neoplasms; Resveratrol; Stilbenes; U937 Cells | 2005 |
Drinking red wine may prevent cancer.
Topics: Anticarcinogenic Agents; Antioxidants; Humans; Neoplasms; Resveratrol; Stilbenes; Wine | 2004 |
The cancer chemopreventive agent resveratrol induces tensin, a cell-matrix adhesion protein with signaling and antitumor activities.
Topics: Actins; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Cell Adhesion; Cell Adhesion Molecules; Cell Line, Tumor; Cell Movement; Cycloheximide; Cytoplasm; Cytoskeleton; DNA, Complementary; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; K562 Cells; Microfilament Proteins; Neoplasm Invasiveness; Neoplasms; Phosphatidylinositol 3-Kinases; Protein Synthesis Inhibitors; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Stilbenes; Tensins; Time Factors | 2005 |
Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-X Protein; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Female; Gene Expression; Humans; Male; Mice; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Neoplasms; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Signal Transduction; src-Family Kinases; STAT3 Transcription Factor; Stilbenes | 2006 |
Chronic treatment with resveratrol induces redox stress- and ataxia telangiectasia-mutated (ATM)-dependent senescence in p53-positive cancer cells.
Topics: Anticarcinogenic Agents; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; DNA-Binding Proteins; HCT116 Cells; Humans; Mitochondria; Neoplasms; Oxidation-Reduction; p38 Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Resveratrol; Stilbenes; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2007 |
Take a break--resveratrol in action on DNA.
Topics: Animals; Antioxidants; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; DNA Damage; DNA Repair; DNA-Binding Proteins; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genome; Humans; Models, Biological; Neoplasms; Protein Serine-Threonine Kinases; Resveratrol; Signal Transduction; Stilbenes; Tumor Suppressor Proteins | 2008 |
"Soybean" in a Haystack? pinpointing an anti-cancer effect.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Colorectal Neoplasms; Garlic; Glycine max; Humans; Neoplasms; Phytotherapy; Plants, Medicinal; Resveratrol; Selenium; Stilbenes; Tea | 1999 |
Benefits of the grape.
Topics: Antioxidants; Heart Diseases; Humans; Male; Neoplasms; Resveratrol; Rosales; Stilbenes; Wine | 1999 |
DNA breakage by resveratrol and Cu(II): reaction mechanism and bacteriophage inactivation.
Topics: Animals; Anticarcinogenic Agents; Bacteriophage lambda; Cattle; Copper; DNA; DNA Damage; Dose-Response Relationship, Drug; Endoribonucleases; Formazans; Free Radical Scavengers; Ions; Neoplasms; Phenanthrolines; Reactive Oxygen Species; Resveratrol; Spectrophotometry; Stilbenes; Thymus Gland; Time Factors; Ultraviolet Rays | 2000 |
Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes.
Topics: Allantois; Angiogenesis Inhibitors; Animals; Cell Division; Chick Embryo; Chorion; Cornea; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Activation; Fibroblast Growth Factor 2; Fibrosarcoma; Lymphokines; Mice; Mitogen-Activated Protein Kinases; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Resveratrol; Rosales; Stilbenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Wine; Wound Healing | 2001 |
The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Aryl Hydrocarbon Hydroxylases; Chemoprevention; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme System; Gas Chromatography-Mass Spectrometry; Humans; Neoplasms; Resveratrol; Stilbenes; Tumor Cells, Cultured; Wine | 2002 |
A culture of mistrust.
Topics: Antineoplastic Agents; Calcium; Carotenoids; Communication Barriers; Diet; Humans; Lycopene; Mass Media; Medical Oncology; Neoplasms; Resveratrol; Solanum lycopersicum; Stilbenes; Wine | 2002 |